<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PLPA-RA-1339R2</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1000687</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Immunology/Cellular Microbiology and Pathogenesis</subject><subject>Immunology/Immunity to Infections</subject><subject>Immunology/Immunomodulation</subject><subject>Immunology/Innate Immunity</subject><subject>Immunology/Leukocyte Activation</subject><subject>Immunology/Leukocyte Signaling and Gene Expression</subject></subj-group></article-categories><title-group><article-title>CD14 Signaling Restrains Chronic Inflammation through Induction of p38-MAPK/SOCS-Dependent Tolerance</article-title><alt-title alt-title-type="running-head">CD14 Signaling Induces p38-Dependent Tolerance</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sahay</surname><given-names>Bikash</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Patsey</surname><given-names>Rebeca L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Eggers</surname><given-names>Christian H.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn1"><sup>&#x000a4;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Salazar</surname><given-names>Juan C.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Radolf</surname><given-names>Justin D.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sellati</surname><given-names>Timothy J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Connecticut Children's Medical Center, Division of Pediatric Infectious Diseases, Hartford, Connecticut, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, Connecticut, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Coburn</surname><given-names>Jenifer</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Medical College of Wisconsin, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>sellatt@mail.amc.edu</email></corresp><fn id="fn1" fn-type="current-aff"><label>&#x000a4;</label><p>Current address: Department of Biomedical Sciences, Quinnipiac University, Hamden, Connecticut, United States of America</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: JCS JDR TJS. Performed the experiments: BS RLP. Analyzed the data: BS JCS TJS. Contributed reagents/materials/analysis tools: CHE JCS JDR. Wrote the paper: BS TJS.</p></fn></author-notes><pub-date pub-type="collection"><month>12</month><year>2009</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>12</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>11</day><month>12</month><year>2009</year></pub-date><volume>5</volume><issue>12</issue><elocation-id>e1000687</elocation-id><history><date date-type="received"><day>7</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>10</day><month>11</month><year>2009</year></date></history><permissions><copyright-statement>Sahay et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Current thinking emphasizes the primacy of CD14 in facilitating recognition of microbes by certain TLRs to initiate pro-inflammatory signaling events and the importance of p38-MAPK in augmenting such responses. Herein, this paradigm is challenged by demonstrating that recognition of live <italic>Borrelia burgdorferi</italic> not only triggers an inflammatory response in the absence of CD14, but one that is, in part, a consequence of altered PI3K/AKT/p38-MAPK signaling and impaired negative regulation of TLR2. CD14 deficiency results in increased localization of PI3K to lipid rafts, hyperphosphorylation of AKT, and reduced activation of p38. Such aberrant signaling leads to decreased negative regulation by SOCS1, SOCS3, and CIS, thereby compromising the induction of tolerance in macrophages and engendering more severe and persistent inflammatory responses to <italic>B. burgdorferi</italic>. Importantly, these altered signaling events and the higher cytokine production observed can be mimicked through shRNA and pharmacological inhibition of p38 activity in CD14-expressing macrophages. Perturbation of this CD14/p38-MAPK-dependent immune regulation may underlie development of infectious chronic inflammatory syndromes.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Macrophages express CD14 which partners with Toll-like receptor 2/1 to recognize bacterial lipoproteins such as those of <italic>Borrelia burgdorferi</italic>, the causative agent of Lyme disease. <italic>In vitro</italic> evidence demonstrates that blocking CD14 recognition of bacterial components ablates innate host cell inflammatory responses. Similarly, blocking downstream p38 kinase activity dampens the cellular response to these same microbial stimuli. This body of work underpins two well-established paradigms which cite the primacy of CD14 in facilitating TLR recognition of microbes to initiate proinflammatory signaling events and the importance of p38 in augmenting such responses. However, contrary to these paradigms, our prior study using a mouse model of Lyme disease demonstrated an association between CD14 deficiency, increased bacterial burden, and more severe and persistent disease. Herein, we provide a mechanistic explanation for this unanticipated host immune response implicating impaired negative regulation of inflammatory signaling pathways as an underlying cause. Consequent to impaired negative regulation the host becomes &#x0201c;intolerant&#x0201d; of continued exposure to bacteria and thus mounts a perpetual inflammatory response to their presence. An intriguing question raised by these findings is whether individual differences in the severity and clinical course of infection might reflect the susceptibility of the patient's innate immune system to tolerization.</p></abstract><counts><page-count count="18"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Toll-like receptor (TLR) signaling orchestrates the innate response to danger-associated molecular patterns (DAMPs) associated with pathogens and/or select endogenous molecules. The principal proinflammatory DAMPs of the spirochetal pathogen <italic>Borrelia burgdorferi</italic>, the causative agent of Lyme disease, are triacylated lipoproteins recognized by heterodimers of TLR2 and TLR1 <xref ref-type="bibr" rid="ppat.1000687-Wooten1">&#x0005b;1&#x0005d;</xref>. Such recognition by TLR2 activates the NF-&#x003ba;B, PI3K/AKT, and MAPK pathways which coordinately regulate inflammation-associated gene activities responsible for host defense <xref ref-type="bibr" rid="ppat.1000687-Arbibe1">&#x0005b;2&#x0005d;</xref>. Although many aspects of Lyme disease pathogenesis remain ill-defined, it generally is accepted that clinical manifestations result primarily, perhaps entirely, from the host's immune response to spirochetes <xref ref-type="bibr" rid="ppat.1000687-Steere1">&#x0005b;3&#x0005d;</xref>. In this latter regard, borrelial lipoproteins are thought to be the chief elicitor of inflammation.</p><p>CD14, a GPI-anchored protein expressed by macrophages (M&#x003a6;) and neutrophils, facilitates pro- and anti-inflammatory cytokine production in response to a variety of DAMPs. Mice deficient for CD14 and their M&#x003a6; exhibit hyporesponsiveness when exposed to DAMPs in the form of a bacterial lysate or purified agonists such as LPS, lipoproteins, and their synthetic analogs <xref ref-type="bibr" rid="ppat.1000687-Antal1">&#x0005b;4&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Haziot1">&#x0005b;6&#x0005d;</xref>. This hyporesponsiveness has been attributed to the lower affinity of non-CD14-complexed LPS for TLR4 <xref ref-type="bibr" rid="ppat.1000687-Gangloff1">&#x0005b;7&#x0005d;</xref>, the requirement for CD14 in MyD88-independent signaling <xref ref-type="bibr" rid="ppat.1000687-Jiang1">&#x0005b;8&#x0005d;</xref>, and/or the inability of p38, a member of the serine/threonine MAPK family, to be induced in the absence of CD14 <xref ref-type="bibr" rid="ppat.1000687-Han1">&#x0005b;9&#x0005d;</xref>. While the majority of the literature suggests that CD14 is indispensable for elaboration of an inflammatory response to its cognate DAMPs <xref ref-type="bibr" rid="ppat.1000687-Antal1">&#x0005b;4&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Haziot1">&#x0005b;6&#x0005d;</xref>, we previously reported that both <italic>in vitro</italic> and <italic>in vivo</italic> recognition of <italic>B. burgdorferi</italic> in the absence of CD14 leads to exaggerated proinflammatory cytokine production and worsening disease <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>. However, in contrast to live bacteria, an equivalent number of lysed spirochetes are approximately 100-fold less stimulatory and are primarily dependent upon CD14 to initiate an inflammatory response from M&#x003a6; <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>.</p><p>At the point of contact between a pathogen and the M&#x003a6; plasma membrane molecules such as CD14, TLRs, and phagocytic receptors coalesce into cholesterol-rich detergent-insoluble/detergent-resistant domains or &#x0201c;lipid rafts&#x0201d; <xref ref-type="bibr" rid="ppat.1000687-Schroeder1">&#x0005b;11&#x0005d;</xref>. These platforms serve as an initiating site for innate immune signaling cascades and bacterial entry into the phagocyte <xref ref-type="bibr" rid="ppat.1000687-Lafont1">&#x0005b;12&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Zaas1">&#x0005b;15&#x0005d;</xref>. CD14, like other GPI anchored proteins, may participate in cellular signaling either by direct association with transmembrane spanning proteins <xref ref-type="bibr" rid="ppat.1000687-Stefanova1">&#x0005b;16&#x0005d;</xref> and/or through regulation of the charge character of the inner leaflet of the plasma membrane which alters recruitment of cellular proteins to the lipid-rich domain <xref ref-type="bibr" rid="ppat.1000687-Kramer1">&#x0005b;17&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Suzuki2">&#x0005b;19&#x0005d;</xref>. Following exposure of host cells to pathogens or their isolated constituents, p38 is activated through phosphorylation <xref ref-type="bibr" rid="ppat.1000687-Schieven1">&#x0005b;20&#x0005d;</xref>. After microbial uptake, the action of p38 drives maturation of the phagosome <xref ref-type="bibr" rid="ppat.1000687-Blander1">&#x0005b;21&#x0005d;</xref>, activates downstream kinases that result in the nuclear translocation of NF-&#x003ba;B <xref ref-type="bibr" rid="ppat.1000687-Olson1">&#x0005b;22&#x0005d;</xref>, and stabilizes cytokine mRNA <xref ref-type="bibr" rid="ppat.1000687-Dean1">&#x0005b;23&#x0005d;</xref>. Because the pleiotropic action of p38 is thought to augment inflammation, the pharmaceutical industry has actively pursued development of p38 inhibitors for the treatment of inflammatory disorders <xref ref-type="bibr" rid="ppat.1000687-Schieven1">&#x0005b;20&#x0005d;</xref>. However, through the induction of tolerance <xref ref-type="bibr" rid="ppat.1000687-Ropert1">&#x0005b;24&#x0005d;</xref>, p38 also has an anti-inflammatory role to play by virtue of its ability to induce suppressors of cytokine signaling 3 (SOCS3) and IL-10 <xref ref-type="bibr" rid="ppat.1000687-Chi1">&#x0005b;25&#x0005d;</xref> which negatively regulates pathogen-induced inflammation <xref ref-type="bibr" rid="ppat.1000687-Bode1">&#x0005b;26&#x0005d;</xref>. Tolerance represents a state of M&#x003a6; unresponsiveness to perpetual exposure to bacterial stimuli <xref ref-type="bibr" rid="ppat.1000687-Medvedev1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Foster1">&#x0005b;28&#x0005d;</xref>.</p><p>Herein, we advance a mechanistic explanation for how CD14 regulates the intensity and duration of host responses to bacterial challenge which distinguishes CD14-dependent from -independent signaling and recognition of live versus lysed <italic>B. burgdorferi</italic>. Using a mouse model of Lyme disease, we show that <italic>B. burgdorferi</italic>-activated CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; release significantly more proinflammatory cytokines and do so in a manner only partially dependent on TLR2. Initial engagement of receptors (<italic>i.e.</italic>, TLR2 and/or non-TLR2) on the surface of CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; by <italic>B. burgdorferi</italic> leads to the accumulation of PI3K in lipid rafts resulting in higher phospho-AKT levels, lower p38 activation, decreased SOCS activity, and increased and persistent inflammation. The perpetual nature of CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; responses to spirochetes is a reflection of the cell's inability to be tolerized via CD14/p38-dependent SOCS induction. Importantly, inhibition of PI3K in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; restores p38 activity to wild-type levels and thus reduces TNF-&#x003b1; release in response to <italic>B. burgdorferi</italic>. Additionally, inhibition of p38 has the commonly observed effect of suppressing proinflammatory responses, but only when cells are exposed to lysed bacteria and not when whole organisms are used as a stimulus. Collectively, our findings challenge the current paradigm by supporting the rather provocative notion that CD14 signaling: i) is entirely dispensable for elaboration of a proinflammatory response to DAMPs other than lipoproteins, ii) is essential for prolonged p38 activation, and iii) serves a critical function in resolution of inflammation through induction of tolerance.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>CD14 deficiency augments TLR-dependent gene activity</title><p>Compared to CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6;, activation of CD14<sup>&#x02212;/&#x02212;</sup> cells by <italic>B. burgdorferi</italic> results in greater transcription and persistent surface expression of TLR2 and a concomitant increase in proinflammatory cytokine production, particularly TNF-&#x003b1; (<xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref> and <xref ref-type="fig" rid="ppat-1000687-g001">Figure 1A</xref>). To rule out the potential influence of developmental defects introduced through genetic mutation of <italic>cd14</italic>, expression of CD14 by M&#x003a6; was transiently targeted through use of shRNA. A pRS-shGFP lentiviral expression vector was used to transduce either a CD14 shRNA or a scrambled control shRNA into CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6;. At 3 days p.i., a 70&#x00025; reduction in the MFI of CD14 expression was observed by flow cytometry (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1B</xref>), an effect confirmed by Western blot analysis (Inset). After incubation with <italic>B. burgdorferi</italic>, CD14 shRNA-expressing cells produced markedly higher TNF-&#x003b1; (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1C</xref>), a trend identical to that observed with <italic>B. burgdorferi</italic>-activated CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1A</xref>).</p><fig id="ppat-1000687-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000687.g001</object-id><label>Figure 1</label><caption><title>Higher <italic>B. burgdorferi</italic>-induced inflammatory gene activity is associated with lower SOCS levels in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6;.</title><p>A) M&#x003a6; isolated from CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> mice were incubated with <italic>B. burgdorferi</italic> at a MOI of 10 for 24 h and TNF-&#x003b1; levels in culture supernatant were measured by CBA. B) Lentiviral transduction was used to knock down CD14 in M&#x003a6; as determined by a reduction in mean fluorescent intensity (MFI) and by Western blot analysis (inset). C) The lentivirus-treated M&#x003a6; were incubated with <italic>B. burgdorferi</italic> for 24 h and TNF-&#x003b1; levels were measured as for (A). D) M&#x003a6; isolated from CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> mice were incubated with <italic>B. burgdorferi</italic> for 3, 6 and 24 h. Total RNA was isolated and used to perform qPCR for simultaneous interrogation of 84 genes associated with TLR signaling. The results presented are the ratio of fold change in HPRT-normalized gene activity in CD14<sup>&#x02212;/&#x02212;</sup> versus CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; and error bars represent SEM calculated on the basis of three independent experiments. E) Total RNA isolated from CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; incubated with <italic>B. burgdorferi</italic> was analyzed by qPCR for <italic>socs1</italic>, <italic>socs3</italic> and <italic>cis</italic>. Results are presented as fold change over respective mock-infected control and were normalized with 18S rRNA transcript. F) Equivalent protein from lysed M&#x003a6; were separated by 12&#x00025; SDS-PAGE, transferred to a PVDF membrane and probed with antibodies directed against SOCS1, SOCS3, CIS or &#x003b2;-actin. G) Total RNA isolated from CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; incubated with <italic>B. burgdorferi</italic> was analyzed by qPCR for <italic>irf1</italic>, <italic>irf7</italic> and <italic>stat1</italic>. Dotted lines denote the 2-fold over mock change considered significant for the purposes of interpretation. H) Equivalent protein from lysed M&#x003a6; were subjected to Western blot analysis using antibodies directed against phospho-specific STAT1 or STAT3, or &#x003b2;-actin. Results represent mean&#x000b1;SEM from three to four independent experiments. &#x0002a;<italic>P</italic>&#x0003c;0.05, &#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.01, &#x0002a;&#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.001.</p></caption><graphic xlink:href="ppat.1000687.g001"/></fig><p>To more broadly evaluate the impact of CD14 deficiency on the M&#x003a6; inflammatory transcriptome, we measured gene activity associated with TLR signaling. Greater transcription of interleukins (<italic>i.e.</italic>, <italic>il1&#x003b1;</italic>, <italic>il1&#x003b2;</italic>, <italic>il2</italic>, <italic>il6</italic>, and <italic>il12</italic>), interferons (<italic>i.e.</italic>, <italic>ifn&#x003b3;</italic>), chemokines (<italic>i.e.</italic>, <italic>ccl2</italic>), growth factors (<italic>i.e.</italic>, <italic>g-csf</italic>), and proinflammatory lipid mediators (<italic>i.e.</italic>, <italic>cox2</italic>) was observed in CD14<sup>&#x02212;/&#x02212;</sup> than in CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1D</xref>); many of these genes are associated with the NF-&#x003ba;B signaling pathway. TLR2 transcript levels, but not those of other TLRs, were elevated 50-fold in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; compared to wild-type cells. Gene induction in CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; peaked at 3 h and returned to baseline by 24 h p.i.. In contrast, CD14<sup>&#x02212;/&#x02212;</sup> cells more actively transcribed these genes at 3 h and did so throughout the course of the experiment (data not shown), suggesting a critical role for CD14 in downmodulation of inflammation.</p></sec><sec id="s2b"><title><italic>B. burgdorferi</italic> fails to trigger expression of negative regulators of TLR signaling in the absence of CD14</title><p>The above findings prompted an evaluation of the impact of CD14 deficiency on negative regulators of TLR signaling which include competitive inhibitors (<italic>e.g.</italic>, IRAKM), protein phosphatases &#x0005b;<italic>e.g.</italic>, MAPK phosphatase 1 (MKP1)&#x0005d;, and E3 ligases (<italic>e.g.</italic>, SOCSs) <xref ref-type="bibr" rid="ppat.1000687-Liew1">&#x0005b;29&#x0005d;</xref>. <italic>B. burgdorferi</italic> induced significantly higher transcription of <italic>socs1</italic> &#x0005b;&#x0223c;3.5-fold by 6 h p.i. (<italic>P</italic>&#x0003c;0.05)&#x0005d;, s<italic>ocs3</italic> &#x0005b;&#x0223c;3.5-fold by 3 h and &#x0223c;2.5-fold by 6 h (<italic>P</italic>&#x0003c;0.01)&#x0005d;, and <italic>cis</italic> &#x0005b;&#x0223c;5.6-fold by 3 h (<italic>P</italic>&#x0003e;0.01)&#x0005d; in CD14<sup>&#x0002b;/&#x0002b;</sup> cells compared to cells lacking CD14 (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1E</xref>). However, by 24 h p.i. transcription of these negative regulators in CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; was indistinguishable. Transcription of <italic>mkp1</italic> and <italic>irakm</italic> was not significantly different in these cells at any time point studied (data not shown). Consistent with their respective transcript levels, increased expression of SOCS1 and CIS was seen in CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6;, whereas little or no expression was detected in their CD14-deficient counterparts (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1F</xref>). Upon inhibition of proteosome-mediated degradation of SOCS3 using MG132 (10 &#x000b5;M), SOCS3 expression only was observed in CD14<sup>&#x0002b;/&#x0002b;</sup> cells (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1F</xref>). Collectively, these findings suggest a critical role for CD14 in negative regulation of TLR signaling and implicate SOCS family members in this process.</p><p>To discover why negative regulation of TLRs is diminished in CD14<sup>&#x02212;/&#x02212;</sup> cells, we examined the expression of three transcription factors known to directly or indirectly regulate transcription of <italic>socs1</italic>, <italic>socs3</italic>, and <italic>cis</italic><xref ref-type="bibr" rid="ppat.1000687-Saito1">&#x0005b;30&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Croker1">&#x0005b;31&#x0005d;</xref>. <italic>B. burgdorferi</italic> induced significantly higher transcription of <italic>irf1</italic> in CD14<sup>&#x0002b;/&#x0002b;</sup> than in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (<italic>P</italic>&#x0003c;0.05) whereas transcription of both <italic>irf7</italic> and <italic>stat1</italic> was significantly higher in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (<italic>P</italic>&#x0003c;0.01 and 0.05, respectively) (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1G</xref>). No differences were seen for <italic>irf3</italic>, <italic>stat3</italic>, or <italic>stat4</italic> (data not shown). Additionally, Western blot analysis revealed that levels of phospho-STAT1 (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1H</xref>), but not phospho-STAT3 (data not shown), were higher in CD14<sup>&#x0002b;/&#x0002b;</sup> than in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6;. Given their capacity to upregulate SOCS, the lower <italic>irf1</italic> transcript levels and STAT1 phosphorylation in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; is consistent with reduced SOCS expression observed in these cells.</p></sec><sec id="s2c"><title>The inflammatory response to <italic>B. burgdorferi</italic> is perpetuated in the absence of CD14</title><p>The mouse model of Lyme disease was used to elucidate the relationship between CD14 signaling, SOCS activity, and disease progression. Arthritis, an inflammatory hallmark of Lyme disease, is a self-limiting process in immunocompetent mice that peaks between 2 and 3 weeks p.i. and typically resolves by 6 weeks <xref ref-type="bibr" rid="ppat.1000687-Moody1">&#x0005b;32&#x0005d;</xref>. Syringe inoculation of mice with <italic>B. burgdorferi</italic> resulted in tibiotarsal joint swelling in CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> mice which peaked at 2 weeks p.i.. Distinct from CD14<sup>&#x0002b;/&#x0002b;</sup> joints wherein swelling (which grossly correlates with arthritis progression) resolved by 3 to 4 weeks p.i., CD14<sup>&#x02212;/&#x02212;</sup> joints were more inflamed than their wild-type counterparts at each time point and remained swollen for the duration of the experiment (<xref ref-type="fig" rid="ppat-1000687-g002">Figure 2A</xref>). Consistent with the more severe and prolonged joint swelling in CD14<sup>&#x02212;/&#x02212;</sup> mice, transcription of <italic>irf1</italic>, <italic>socs1</italic>, and <italic>socs3</italic> in joint tissue was greatly reduced compared to wild-type mice (<xref ref-type="fig" rid="ppat-1000687-g002">Figure 2B</xref>). Given the elevated cytokine production (<italic>e.g.</italic>, TNF-&#x003b1; and IFN-&#x003b3;, Figure S3 and <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>) at one week in <italic>B. burgdorferi</italic>-infected CD14<sup>&#x02212;/&#x02212;</sup> mice, one might have predicted decreased spirochete numbers through enhanced antimicrobial M&#x003a6; effector functions later (at 6 weeks) in the disease process; surprisingly, all organs recovered from CD14<sup>&#x02212;/&#x02212;</sup> mice at this time point, with the exception of the heart, had heavier bacterial burdens than those of wild-type animals (<xref ref-type="fig" rid="ppat-1000687-g002">Figure 2C</xref>). A similar increase in Lyme disease susceptibility characterized by increased tibiotarsal joint thickness (<xref ref-type="supplementary-material" rid="ppat.1000687.s001">Figure S1</xref>), enhanced production of pro-inflammatory cytokines (<xref ref-type="supplementary-material" rid="ppat.1000687.s002">Figure S2</xref>), and greater bacterial burden (<xref ref-type="supplementary-material" rid="ppat.1000687.s003">Table S1</xref>) also was observed in CD14<sup>&#x02212;/&#x02212;</sup> C57BL/6 mice. These results are particularly noteworthy as C57BL/6 mice are highly resistant to the development of Lyme pathology <xref ref-type="bibr" rid="ppat.1000687-Ma1">&#x0005b;33&#x0005d;</xref>, and corroborate the importance of CD14 in host immunity irrespective of inherent differences in disease susceptibility.</p><fig id="ppat-1000687-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000687.g002</object-id><label>Figure 2</label><caption><title>CD14 deficiency is associated with greater inflammation and higher bacterial burden with reduced <italic>socs</italic> transcription in response to <italic>B. burgdorferi</italic>.</title><p>A) CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> mice were infected with 1&#x000d7;10<sup>5</sup><italic>B. burgdorferi</italic> and tibiotarsal joint thickness was measured at 1 week intervals. The horizontal bars indicate mean thickness for each group and the data are representative of two independent experiments (n&#x0200a;&#x0003d;&#x0200a;24). B) Total RNA was isolated from the tibiotarsal joints of CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> mice (n&#x0200a;&#x0003d;&#x0200a;6), an equal amount of RNA was pooled from each joint and 0.5 &#x000b5;g of pooled RNA was used for preparing cDNA. The cDNA was analyzed by qPCR to determine the levels of <italic>irf1</italic>, <italic>socs1</italic> and <italic>socs3</italic> transcript. Results represent mean&#x000b1;SEM from two independent experiments wherein samples were run in triplicate. &#x0002a;<italic>P</italic>&#x0003c;0.05, &#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.01. C) DNA from the indicated organs was collected 6 weeks p.i. and the bacterial burden was determined using Taqman&#x000ae; probes for <italic>flaB</italic> of <italic>B. burgdorferi</italic>; murine <italic>nidogen</italic> served as a control. Results represent mean&#x000b1;SEM from two independent experiments (n&#x0200a;&#x0003d;&#x0200a;24) wherein samples were run in triplicate. &#x0002a;<italic>P</italic>&#x0003c;0.05, &#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.01.</p></caption><graphic xlink:href="ppat.1000687.g002"/></fig></sec><sec id="s2d"><title>Killing, but not internalization, of <italic>B. burgdorferi</italic> by M&#x003a6; is impaired in the absence of CD14</title><p>To determine whether the hyper-responsiveness of CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (<xref ref-type="fig" rid="ppat-1000687-g001">Figure 1A</xref>) and/or increased bacterial burden in CD14<sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="ppat-1000687-g002">Figure 2C</xref>) reflected differences in binding and uptake of spirochetes we evaluated phagocytosis using GFP-expressing <italic>B. burgdorferi</italic>. The role of CD14 in the binding and/or internalization of spirochetes by M&#x003a6; was evaluated by flow cytometry and two-photon laser scanning confocal microscopy. CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were incubated at 4&#x000b0;C and 37&#x000b0;C for 6 h with or without GFP-labeled <italic>B. burgdorferi</italic> at a MOI of 10; this allowed for discrimination between binding of the spirochete to the cell surface and active phagocytosis. At 4&#x000b0;C, a temperature which impairs bacterial uptake, the absence of CD14 had no effect on either the percentage of cells positive for GFP or the MFI of the positive population (<xref ref-type="fig" rid="ppat-1000687-g003">Figure 3A</xref>). Similarly, at 37&#x000b0;C, a temperature permissive for uptake of bacteria, M&#x003a6; of both genotypes bound and phagocytosed an equivalent number of spirochetes. Comparable results were obtained when a MOI of 100 was used (data not shown). The phagocytic index was calculated as described elsewhere <xref ref-type="bibr" rid="ppat.1000687-Gresham1">&#x0005b;34&#x0005d;</xref>, and confirmed that the absence of CD14 does not alter the capacity of M&#x003a6; to bind and internalize <italic>B. burgdorferi</italic> (<xref ref-type="fig" rid="ppat-1000687-g003">Figure 3B</xref>). Flow cytometry results were corroborated through visualization of spirochetes bound to the cell surface and found within the cell's interior using two-photon laser confocal microscopy. For these experiments a MOI of 100 was used to increase the number of organisms per field. The distribution of spirochetes associated with CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; was identical as determined by color depth coding analysis of images of spirochetes (which are green) within the middle optical sections of the Z-stack of cells (<xref ref-type="fig" rid="ppat-1000687-g003">Figure 3C</xref>) and as seen in entire optical Z-stack for wild-type and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (<xref ref-type="supplementary-material" rid="ppat.1000687.s005">Video S1</xref> and <xref ref-type="supplementary-material" rid="ppat.1000687.s006">S2</xref>, respectively). The amount of green signal as a percentage of the total area represents a measure of internalized spirochetes and was found to be similar in both CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (<xref ref-type="fig" rid="ppat-1000687-g003">Figure 3D</xref>). Though more sparsely populated with spirochetes, similar results were obtained visualizing M&#x003a6; monolayers incubated with <italic>B. burgdorferi</italic> using a MOI of 10 (data not shown).</p><fig id="ppat-1000687-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000687.g003</object-id><label>Figure 3</label><caption><title><italic>B. burgdorferi</italic>-induced transcription of <italic>inos</italic>, but not phagocytic uptake of spirochetes, is impaired by CD14 deficiency.</title><p>A) M&#x003a6; were incubated with GFP-expressing <italic>B. burgdorferi</italic> at a MOI of 10 at 4&#x000b0;C and 37&#x000b0;C for 6 h. Phagocytosis of <italic>B. burgdorferi</italic> was determined by flow cytometry. B) Phagocytic indices were calculated based upon the results of five independent flow cytometric experiments. C) M&#x003a6; were incubated with GFP-expressing <italic>B. burgdorferi</italic> at a MOI of 100 for 6 h and the cytoplasm and nucleus were stained with wheat-germ agglutinin-Alexa Fluor 647 and DAPI, respectively. Optical sections were collected at every 0.5&#x000b5;m and were used to generate orthogonal sections (upper panel), depth coded images (middle panel) and green color extraction (lower panel) (see <xref ref-type="sec" rid="s4">Methods</xref>). D) The green area of 10 randomly chosen fields from both genotypes was used for statistical analysis. E) <italic>inos</italic> transcript levels were determined by qPCR using RNA isolated from M&#x003a6; incubated with <italic>B. burgdorferi</italic> or F) using RNA pooled from joints isolated from infected mice, as described in <xref ref-type="fig" rid="ppat-1000687-g002">Figure 2</xref>. Results represent mean&#x000b1;SEM from two to five independent experiments. &#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.01, &#x0002a;&#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.001.</p></caption><graphic xlink:href="ppat.1000687.g003"/></fig><p>Although differences in binding and phagocytosis were not observed, the antimicrobial effector functions of CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; might differ and thus explain the differential <italic>in vivo</italic> bacterial burden (<xref ref-type="fig" rid="ppat-1000687-g002">Figure 2C</xref>). Killing of bacteria within the phagolysosomal compartment depends, at least in part, on the production of RNS/ROS <xref ref-type="bibr" rid="ppat.1000687-Flannagan1">&#x0005b;35&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Steinberg1">&#x0005b;36&#x0005d;</xref>. Assessing gene activity both <italic>in vitro</italic> and <italic>in vivo</italic> it was observed that <italic>inos</italic> transcript levels were significantly higher in cells and joints from CD14<sup>&#x0002b;/&#x0002b;</sup> mice (<xref ref-type="fig" rid="ppat-1000687-g003">Figure 3E and F</xref>, respectively). Though not directly linked experimentally these differences might underlie the two-fold more culturable spirochetes being recovered from 6 h-infected CD14<sup>&#x02212;/&#x02212;</sup> (7,252 bacteria/ml) versus CD14<sup>&#x0002b;/&#x0002b;</sup> (3,567 bacteria/ml) M&#x003a6; as measured using a modified tissue culture-infective dose method. In consequence, prolonged survival of <italic>B. burgdorferi</italic> internalized by CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; might correlate with their persistence <italic>in vivo</italic>.</p></sec><sec id="s2e"><title>CD14 signaling regulates activation of the p38-MAPK pathway</title><p>p38-STAT1-IRF1 signaling positively regulates <italic>socs</italic> activity <xref ref-type="bibr" rid="ppat.1000687-Bode1">&#x0005b;26&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Saito1">&#x0005b;30&#x0005d;</xref> and negatively regulates <italic>tlr2</italic> activity <xref ref-type="bibr" rid="ppat.1000687-Li1">&#x0005b;37&#x0005d;</xref>. To determine whether CD14 signaling modulates this axis, the phosphorylation state of p38 was evaluated in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6;. In contrast to cells expressing CD14, detectable levels of phospho-p38 were observed only transiently in <italic>B. burgdorferi</italic>-stimulated CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (<xref ref-type="fig" rid="ppat-1000687-g004">Figure 4A</xref>). This result was confirmed and extended using the phospho-specific Cytometric Bead Array (CBA) assay which showed that <italic>B. burgdorferi</italic> stimulated higher phospho-p38, but not phospho-Erk or Jnk, levels in CD14<sup>&#x0002b;/&#x0002b;</sup> than in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (data not shown). The dependence of p38 activation on CD14 was confirmed using the shRNA targeting strategy described above. As seen in <xref ref-type="fig" rid="ppat-1000687-g004">Figure 4B</xref>, CD14 shRNA, but not a scrambled shRNA control, dampened the <italic>B. burgdorferi</italic>-induced phosphorylation of p38.</p><fig id="ppat-1000687-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000687.g004</object-id><label>Figure 4</label><caption><title>CD14 deficiency results in dysregulated p38-MAPK signaling and cytokine production in response to <italic>B. burgdorferi</italic>.</title><p>A) Equal protein from lysates of CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; incubated with <italic>B. burgdorferi</italic> were separated by 10&#x00025; SDS-PAGE, transferred to a nitrocellulose membrane and probed with phospho-p38 and &#x003b2;-actin antibodies. B) CD14 was knocked down using lentiviral transduction as in <xref ref-type="fig" rid="ppat-1000687-g001">Figure 1B &#x00026; C</xref>. M&#x003a6; were incubated with <italic>B. burgdorferi</italic> for 30 min and phospho-p38 and &#x003b2;-actin were detected as in <xref ref-type="fig" rid="ppat-1000687-g004">Figure 4A</xref>. C) CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; were treated with DMSO, SB202190 (0.5 &#x000b5;M) or arctigenin (1 &#x000b5;M) for 30 min prior to incubation with <italic>B. burgdorferi</italic> and total RNA was analyzed by qPCR for <italic>inos</italic> and <italic>socs3</italic>. D) CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; were treated as described in (C), and culture supernatants were analyzed for TNF-&#x003b1; by CBA. E) CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; were treated with DMSO or increasing concentrations of arctigenin or SB202190 for 30 min prior to incubation with <italic>B. burgdorferi</italic>. Cell culture supernatants were collected 24 h p.i. and TNF-&#x003b1; was measured by CBA. F) CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; were treated with DMSO or increasing concentrations of SB203580 for 30 min prior to incubation with live <italic>B. burgdorferi</italic> or <italic>B. burgdorferi</italic> lysate (10&#x000b5;g/ml). Cell culture supernatants were assayed for TNF-&#x003b1; by CBA. Results represent mean&#x000b1;SEM from two to five independent experiments. &#x0002a;<italic>P</italic>&#x0003c;0.05, &#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.01, &#x0002a;&#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.001.</p></caption><graphic xlink:href="ppat.1000687.g004"/></fig><p>Pharmacological inhibition of p38 has implicated this molecule in proinflammatory responses to a variety of microbial, host, and environmental stimuli <xref ref-type="bibr" rid="ppat.1000687-Schieven1">&#x0005b;20&#x0005d;</xref>. Thus, the coexistence of higher levels of phospho-p38 with lower cytokine production by <italic>B. burgdorferi</italic>-stimulated CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; is contrary to much of the published literature. To clarify the role of p38 in our model, arctigenin (a general MAPK inhibitor) and SB202190 (a p38-specific inhibitor) were used. Both inhibitors significantly lowered the transcription of <italic>inos</italic> and <italic>socs3</italic> in response to <italic>B. burgdorferi</italic> (<xref ref-type="fig" rid="ppat-1000687-g004">Figure 4C</xref>), thereby relieving the SOCS-mediated inhibition of TNF-&#x003b1; release by wild-type cells (<xref ref-type="fig" rid="ppat-1000687-g004">Figure 4D</xref>), an effect that was dose-dependent (<xref ref-type="fig" rid="ppat-1000687-g004">Figure 4E</xref>). Enhanced TNF-&#x003b1; release also is observed with another p38-specific inhibitor, SB203580, but not when cells were co-incubated with a borrelial lysate (10 &#x000b5;g/ml) (<xref ref-type="fig" rid="ppat-1000687-g004">Figure 4F</xref>). This latter finding is reflective of the widely-reported observation that p38 inhibition ablates cellular inflammatory responses to isolated bacterial DAMPs <xref ref-type="bibr" rid="ppat.1000687-Olson1">&#x0005b;22&#x0005d;</xref>, <xref ref-type="bibr" rid="ppat.1000687-Hollenbach1">&#x0005b;38&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Nash1">&#x0005b;41&#x0005d;</xref> and underscores the difference between stimulation of cells with live spirochetes as opposed to spirochetal lysates or lipoproteins <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Olson1">&#x0005b;22&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Cruz1">&#x0005b;42&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Moore1">&#x0005b;43&#x0005d;</xref>.</p></sec><sec id="s2f"><title>CD14 deficiency alters PI3K recruitment to the lipid raft, AKT activity, and downstream p38 signaling</title><p>p38 is negatively regulated by AKT, a serine-threonine kinase activated via PI3K <xref ref-type="bibr" rid="ppat.1000687-Gratton1">&#x0005b;44&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Kim2">&#x0005b;45&#x0005d;</xref>. To determine whether the diminished p38 activity in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; simply reflected AKT function, the levels of phospho-AKT were measured in <italic>B. burgdorferi</italic>-activated M&#x003a6;. The phospho-AKT pool in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; was significantly increased above baseline and beyond that seen in cells expressing CD14 (<xref ref-type="fig" rid="ppat-1000687-g005">Figure 5A</xref>). Of note, peak phosphorylation of AKT in CD14<sup>&#x02212;/&#x02212;</sup> cells (seen at 5 min) immediately preceded the disappearance of phospho-p38 (<xref ref-type="fig" rid="ppat-1000687-g004">Figure 4A</xref>, 10 min) suggesting a strict regulatory network. The PI3K inhibitors wortmannin and Ly294002 were used to determine whether elevated AKT activity was responsible for the decreased phospho-p38 levels in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6;. As shown in <xref ref-type="fig" rid="ppat-1000687-g005">Figure 5B</xref>, exposure of cells to either inhibitor reduced the phospho-AKT pool. Blocking PI3K-dependent AKT function via Ly294002, but not wortmannin, resulted in a &#x0223c;2-fold increase in the phospho-p38 pool following co-incubation with <italic>B. burgdorferi</italic> (<xref ref-type="fig" rid="ppat-1000687-g005">Figure 5B</xref>). The inability of wortmannin to have the same effect as Ly294002 may be attributable to its known &#x0201c;off target&#x0201d; inhibition of the MAPK pathway <xref ref-type="bibr" rid="ppat.1000687-Ferby1">&#x0005b;46&#x0005d;</xref>. To explore further how signaling through the PI3K/AKT axis influences <italic>B. burgdorferi</italic>-induced CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; activation, spirochetes were incubated with cells that were untreated or treated with Ly294002. Enhanced phosphorylation of p38 (<xref ref-type="fig" rid="ppat-1000687-g005">Figure 5B</xref>) correlated with a profound reduction in <italic>B. burgdorferi</italic>-induced TNF-&#x003b1; secretion (<xref ref-type="fig" rid="ppat-1000687-g005">Figure 5C</xref>), an effect that was dose-dependent (<xref ref-type="fig" rid="ppat-1000687-g005">Figure 5D</xref>). Similar results were obtained with the use of another PI3K inhibitor, PI-103 <xref ref-type="bibr" rid="ppat.1000687-Knight1">&#x0005b;47&#x0005d;</xref>, (data not shown). Perturbation of the PI3K/AKT/p38 axis in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; reduced cytokine production to the level observed in CD14<sup>&#x0002b;/&#x0002b;</sup> cells (<xref ref-type="fig" rid="ppat-1000687-g005">Figure 5C</xref>).</p><fig id="ppat-1000687-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000687.g005</object-id><label>Figure 5</label><caption><title>Inhibition of <italic>B. burgdorferi</italic>-induced AKT activation in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; reestablishes p38 activity and restores negative regulation of cytokine production.</title><p>A) Equal protein from lysed CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; incubated with <italic>B. burgdorferi</italic> were separated by SDS-PAGE, transferred to a nitrocellulose membrane and probed for phospho-AKT and &#x003b2;-actin. B) CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were treated with DMSO or PI3K inhibitors &#x0005b;wortmannin (100nM) or Ly294002 (100&#x000b5;M)&#x0005d; for 30 min prior to incubation with <italic>B. burgdorferi</italic>. Western blots were probed with phospho-specific AKT and p38 antibodies, then striped and reprobed for total AKT, p38 and &#x003b2;-actin. C) CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were treated with Ly294002 (100&#x000b5;M) for 30 min prior to incubation with <italic>B. burgdorferi</italic> for 3 and 6 h. Culture supernatants were assayed for TNF-&#x003b1; by CBA. TNF-&#x003b1; release by stimulated CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; served as a control. D) CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were treated with DMSO or LY294002 for 30 min prior to incubation with <italic>B. burgdorferi</italic>. Culture supernatants were collected 24 h p.i. and TNF-&#x003b1; was measured by CBA. E) Lipid rafts were isolated from CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; incubated with or without <italic>B. burgdorferi</italic> at a MOI of 10 for 5 min. An equal volume of lipid raft and cytosolic fractions were separated by 10&#x00025; SDS-PAGE, transferred to a nitrocellulose membrane and probed with antibodies directed against PI3K, flotillin-1, and &#x003b2;-actin. Results represent mean&#x000b1;SEM from two to five independent experiments. &#x0002a;&#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.001.</p></caption><graphic xlink:href="ppat.1000687.g005"/></fig><p>PI3K translocates from the cytosol to the inner leaflet of the plasma membrane (<italic>i.e.</italic>, cytoplasmic face of the lipid raft) upon activation of M&#x003a6; by various DAMPs <xref ref-type="bibr" rid="ppat.1000687-Arcaro1">&#x0005b;48&#x0005d;</xref>. Given the capacity of PI3K to phosphorylate AKT we characterized the composition of the lipid raft formed during the interaction of <italic>B. burgdorferi</italic> with CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; to uncover the mechanism(s) whereby the phospho-AKT pool is greater in cells lacking CD14. Lipid raft and non-raft fractions were isolated from cells incubated with or without <italic>B. burgdorferi</italic> for 5 min. The lipid raft and cytosolic fractions were probed for PI3K, flotillin-1 (a lipid raft marker), and actin (a cytosolic marker). The only lipid raft fraction to contain significant amounts of PI3K was from the CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; incubated with <italic>B. burgdorferi</italic> (<xref ref-type="fig" rid="ppat-1000687-g005">Figure 5E</xref>). Some flotillin-1 was present in the non-raft fraction of both cell types following incubation with <italic>B. burgdorferi</italic> and likely is due to tethering of the lipid raft to the actin cytoskeleton during phagocytosis <xref ref-type="bibr" rid="ppat.1000687-Dermine1">&#x0005b;49&#x0005d;</xref>, which would inhibit the ability of those rafts to float on a sucrose gradient. These data suggest that regulated localization of PI3K (and likely other molecules) to <italic>B. burgdorferi</italic>-induced lipid rafts links proximal membrane events to distal intracellular signaling cascades.</p></sec><sec id="s2g"><title>In the absence of CD14, <italic>B. burgdorferi</italic>-stimulated cytokine production is both dependent and independent of TLR2 and PI3K signaling</title><p>Coordinate signaling through CD14 and TLR2 activates PI3K, NF-&#x003ba;B, and p38-MAPK pathways <xref ref-type="bibr" rid="ppat.1000687-Arbibe1">&#x0005b;2&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Matsuzawa1">&#x0005b;50&#x0005d;</xref> to orchestrate both the initiation and resolution of inflammatory responses to <italic>B. burgdorferi</italic>. CD14 deficiency alters PI3K localization to lipid rafts and excessive phosphorylation of AKT along with higher transcription and surface expression of TLR2 is the result. Since TLR2 signaling regulates PI3K activity and leads to AKT activation <xref ref-type="bibr" rid="ppat.1000687-Arbibe1">&#x0005b;2&#x0005d;</xref>, we asked whether higher TNF-&#x003b1; production by <italic>B. burgdorferi</italic>-stimulated CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; depends upon TLR2-mediated activation of AKT and/or engagement of another non-TLR2 receptor(s). To better appreciate the individual and combined contribution of CD14 and TLR2 signaling to the M&#x003a6; response to <italic>B. burgdorferi</italic>, mice deficient for CD14 or TLR2 (each backcrossed 10 generations onto a C3H/HeN background) were crossed to establish animals that are homozygous recessive for both loci. M&#x003a6; expressing CD14 and TLR2 and those deficient for individual or both loci were co-incubated with spirochetes and TNF-&#x003b1; levels were measured (<xref ref-type="fig" rid="ppat-1000687-g006">Figure 6A</xref>). In the absence of CD14, TNF-&#x003b1; production was significantly higher compared to their wild-type counterparts at 24 h p.i.. TLR2 deficiency had the opposite effect insofar as release of TNF-&#x003b1; (<xref ref-type="fig" rid="ppat-1000687-g006">Figure 6A</xref>) and other cytokines (data not shown) was significantly reduced compared to wild-type M&#x003a6;. Despite this reduction, cytokine release by TLR2<sup>&#x02212;/&#x02212;</sup> M&#x003a6; was greater than that observed with unstimulated control cells (<italic>P</italic>&#x0003c;0.01), implicating the existence of a TLR2-independent pathway, one that may or may not be triggered by non-lipoprotein spirochetal constituents. Interestingly, the cell's capacity to secrete TNF-&#x003b1; in the absence of both TLR2 and CD14 was partially or fully restored to the levels released by CD14<sup>&#x02212;/&#x02212;</sup> and wild-type M&#x003a6;, respectively. Restoration of TNF-&#x003b1; production by CD14<sup>&#x02212;/&#x02212;</sup>/TLR2<sup>&#x02212;/&#x02212;</sup> M&#x003a6; further supports the notion that <italic>B. burgdorferi</italic>-induced signaling is not solely dependent upon TLR2 signaling, nor is CD14 signaling as demonstrated by the phenotypic difference in cytokine response observed between TLR2<sup>&#x02212;/&#x02212;</sup> M&#x003a6; and CD14<sup>&#x02212;/&#x02212;</sup>/TLR2<sup>&#x02212;/&#x02212;</sup> M&#x003a6; (<xref ref-type="fig" rid="ppat-1000687-g006">Figure 6A</xref>). These findings raise the intriguing question of what ultimately controls cytokine production in the absence of both the CD14 and TLR2 pathways. As seen in <xref ref-type="fig" rid="ppat-1000687-g006">Figure 6B</xref>, production of a variety of cytokines by CD14<sup>&#x02212;/&#x02212;</sup>/TLR2<sup>&#x02212;/&#x02212;</sup> M&#x003a6; is ablated in the absence of PI3K activity. This result suggests that both TLR2-dependent and -independent activation of PI3K contributes to the hyper-inflammatory state in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; induced by <italic>B. burgdorferi</italic>. More broadly, it also demonstrates that, notwithstanding similarities in the exaggerated Lyme disease phenotype observed in CD14<sup>&#x02212;/&#x02212;</sup> and TLR2<sup>&#x02212;/&#x02212;</sup> mice <xref ref-type="bibr" rid="ppat.1000687-Wooten2">&#x0005b;51&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Wooten3">&#x0005b;52&#x0005d;</xref>, these two signaling pathways are not entirely synonymous.</p><fig id="ppat-1000687-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000687.g006</object-id><label>Figure 6</label><caption><title>TLR2 plays a partial role in both CD14-dependent and -independent cytokine production.</title><p>A) M&#x003a6; isolated from CD14<sup>&#x0002b;/&#x0002b;</sup>, CD14<sup>&#x02212;/&#x02212;</sup>, TLR2<sup>&#x02212;/&#x02212;</sup> and CD14<sup>&#x02212;/&#x02212;</sup>/TLR2<sup>&#x02212;/&#x02212;</sup> mice were incubated with <italic>B. burgdorferi</italic> and culture supernatants were assayed for TNF-&#x003b1; by CBA. B) <italic>B. burgdorferi</italic> was incubated with M&#x003a6; isolated from CD14<sup>&#x02212;/&#x02212;</sup>/TLR2<sup>&#x02212;/&#x02212;</sup> mice in the presence of DMSO or 100&#x000b5;M Ly294002 for 24 h and cytokines were measured by CBA. Results represent mean&#x000b1;SEM from three independent experiments. &#x0002a;&#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.001.</p></caption><graphic xlink:href="ppat.1000687.g006"/></fig></sec><sec id="s2h"><title>CD14 licenses M&#x003a6; to become tolerant to perpetual bacterial stimulation</title><p>TLR activation of M&#x003a6; concomitantly triggers cytokine production and its negative regulation to temper the extent and duration of inflammation thereby mitigating immunopathology. Given the role of p38 in the induction of tolerance <xref ref-type="bibr" rid="ppat.1000687-Ropert1">&#x0005b;24&#x0005d;</xref> and the observation that <italic>B. burgdorferi</italic> induces lower p38 activity in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6;, we asked whether these cells fail to become tolerant to perpetual stimulation by spirochetes. To address this question, CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were incubated with medium alone or <italic>B. burgdorferi</italic> at a MOI of 10 for 12 h. Afterwards, cells were extensively washed and reexposed to <italic>B. burgdorferi</italic> at a MOI of 10 for an additional 6 h (<xref ref-type="fig" rid="ppat-1000687-g007">Figure 7A</xref>). Upon primary exposure, cells lacking CD14 secreted significantly more TNF-&#x003b1; than their wild-type counterparts (<italic>P</italic>&#x0003c;0.05). Also as anticipated, CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; receiving a primary exposure (non-tolerized) released significantly more cytokine than cells which were reexposed to spirochetes (tolerized) (<italic>P</italic>&#x0003c;0.001). In contrast, the amount of TNF-&#x003b1; produced by CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; receiving a primary exposure to <italic>B. burgdorferi</italic> was identical to that released by cells after reexposure and significantly greater than that released by tolerized CD14<sup>&#x0002b;/&#x0002b;</sup> cells (<italic>P</italic>&#x0003c;0.001). These data support a novel and indispensable role for CD14-dependent p38 regulation of M&#x003a6; function through the induction of tolerance to natural bacterial infection.</p><fig id="ppat-1000687-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000687.g007</object-id><label>Figure 7</label><caption><title>CD14-dependent signaling is a requirement for <italic>B. burgdorferi</italic>-induced tolerance in M&#x003a6;.</title><p>A) CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were incubated with <italic>B. burgdorferi</italic> at a MOI of 10 for 12 h (primary exposure). Cell monolayers were washed extensively followed by reexposure (secondary exposure) to medium containing <italic>B. burgdorferi</italic> for an additional 6 h. The TNF-&#x003b1; level in culture supernatants from cells rexposed to spirochetes was compared with levels released by M&#x003a6; which received only a primary exposure to <italic>B. burgdorferi</italic>. B) A schematic diagram illustrating CD14-dependent and -independent signaling events in response to <italic>B. burgdorferi</italic>. In the absence of CD14 neither binding nor uptake of <italic>B. burgdorferi</italic> via a putative Phagocytic Receptor &#x0201c;Y&#x0201d; is affected. However, localization of PI3K to the signaling platform is altered, perhaps owing to the presence of Receptor &#x0201c;X&#x0201d;, which increases the pool of phospho-AKT resulting in only transient p38 activity. Impaired p38 activity correlates with increased transcription and expression of TLR2, reduced activation of STAT1 and IRF1, and decreased induction of SOCS, all of which are necessary to modulate the intensity and duration of Lyme borreliosis. Ultimately, it is CD14-dependent induction of p38-mediated SOCS activity which regulates the intensity and duration of macrophage response to <italic>B. burgdorferi</italic> through the induction of tolerance. The size of the red circles indicates the degree of phosphorylation of the indicated molecule and the size of the individual molecules is reflective of relative transcript/protein levels. The thickness of lines in the model reflects the intensity of the positive or negative action on downstream molecules.</p></caption><graphic xlink:href="ppat.1000687.g007"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>Coordinate signaling through CD14 and TLR2 orchestrates both the initiation and resolution of inflammatory responses to <italic>B. burgdorferi</italic>. During natural infection, initiation of the host response begins with CD14 recognition of borrelial lipoproteins and subsequent activation of TLR2 <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Wooten3">&#x0005b;52&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Wooten4">&#x0005b;53&#x0005d;</xref>. As described herein and elsewhere <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>, the absence of CD14 results in greater bacterial burden, more severe histopathology, and dysregulated production of a variety of immunomodulators. Contrary to current thinking, we demonstrate that CD14 signaling is dispensable for the induction of inflammation and, instead, tempers the intensity (<italic>e.g.</italic>, cytokine levels) and duration (<italic>e.g.</italic>, joint swelling) of innate inflammatory responses to <italic>B. burgdorferi</italic>. In the face of continued exposure to stimuli of bacterial origin this inflammatory &#x0201c;temperance&#x0201d; reflects negative regulation of TLR signaling which tolerizes M&#x003a6; via the action of SOCS. In turn, SOCS activity is modulated via the PI3K/AKT/p38-MAPK pathway. The initiation of these signaling events occurs at the contact surface between the spirochete membrane and that of the phagocyte (<xref ref-type="fig" rid="ppat-1000687-g007">Figure 7B</xref>).</p><p>Despite the fact they comprise only 0.5&#x00025; of eukaryotic cellular proteins, GPI-anchored polypeptides (<italic>e.g.</italic>, CD14) have diverse roles in cellular physiology - from contributing to cell development and viability to host cell defense against microbial insults <xref ref-type="bibr" rid="ppat.1000687-Mayor1">&#x0005b;54&#x0005d;</xref>. Due to the hydrophobic nature of GPI-anchors such proteins constitutively reside in cholesterol-rich detergent-insoluble/detergent-resistant membranes <xref ref-type="bibr" rid="ppat.1000687-Brown1">&#x0005b;55&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Brown2">&#x0005b;56&#x0005d;</xref>. These lipid rafts serve as signaling platforms for various receptors, the best example of which is the T-cell receptor (TCR). Lacking an extended cytoplasmic tail, the TCR resides outside lipid rafts until engaged through recognition of MHC-peptide complex displayed on antigen presenting cells <xref ref-type="bibr" rid="ppat.1000687-Leupin1">&#x0005b;57&#x0005d;</xref>. Upon ligand binding, the TCR is recruited to the lipid raft where it associates with kinase signaling components such as Lck and Lat. With TCR engagement there is a concomitant exclusion of the phosphatase CD45 from the lipid raft to prevent inactivation of kinases in the signaling platform <xref ref-type="bibr" rid="ppat.1000687-Leupin1">&#x0005b;57&#x0005d;</xref>. Accumulating evidence suggests that lipid rafts also are important in initial bacterial and viral recognition and internalization of pathogens by the M&#x003a6; <xref ref-type="bibr" rid="ppat.1000687-Rosenberger1">&#x0005b;58&#x0005d;</xref>. Depending upon the ligand, different receptor components, adaptor proteins, and kinases/phosphatases coalesce within lipid rafts along with CD14 and TLRs to orchestrate cellular responses to DAMPs <xref ref-type="bibr" rid="ppat.1000687-Pfeiffer1">&#x0005b;59&#x0005d;</xref>. Engagement of receptors residing within the lipid raft alters the surface potential of the inner leaflet of the plasma membrane thus regulating recruitment of non-receptor dependent signaling molecules (<italic>e.g.</italic>, PI3K) <xref ref-type="bibr" rid="ppat.1000687-Yeung1">&#x0005b;60&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Yeung2">&#x0005b;61&#x0005d;</xref>. We found that following activation by <italic>B. burgdorferi</italic>, significantly more PI3K is recruited to the lipid rafts of M&#x003a6; which lack CD14 than those expressing CD14. Thus, PI3K appears to link the spirochete-M&#x003a6; plasma membrane &#x0201c;interaction&#x0201d; platform with the AKT/p38-MAPK pathway within the cytosol. Perhaps analogous to the partitioning of CD45 during TCR signaling, it is intriguing to speculate whether a specific protein(s) is excluded from and/or recruited to the lipid raft depending on whether CD14 is present or absent. Such a protein(s) is represented as &#x0201c;Receptor X&#x0201d; in our model (<xref ref-type="fig" rid="ppat-1000687-g007">Figure 7B</xref>). In the former case exclusion of a protein(s) may eliminate a necessary docking partner for PI3K (<italic>e.g.</italic>, Src kinases/c-Kit, <xref ref-type="bibr" rid="ppat.1000687-Arcaro1">&#x0005b;48&#x0005d;</xref>) and in the latter case, a protein(s) might actively prohibit entry of PI3K into a CD14-containing lipid raft. Alternatively, differential distribution of lipids may distinguish the initiation of signaling within CD14-containing and -deficient lipid rafts <xref ref-type="bibr" rid="ppat.1000687-Graeme1">&#x0005b;62&#x0005d;</xref>. As an example, receptors are differentially recruited into ceramide- versus cholesterol-rich lipid rafts <xref ref-type="bibr" rid="ppat.1000687-AbdelShakor1">&#x0005b;63&#x0005d;</xref>.</p><p>Upon binding of pathogens to the phagocyte surface, receptor-dependent cytoskeletal rearrangements occur via recruitment of actin-related proteins to the lipid raft, a necessary prelude to internalization of <italic>B. burgdorferi</italic><xref ref-type="bibr" rid="ppat.1000687-Shin1">&#x0005b;64&#x0005d;</xref>. A variety of molecules have been implicated in the process of binding and phagocytosis of spirochetes including members of the integrin family such as &#x003b1;<sub>3</sub>&#x003b2;<sub>1</sub>, &#x003b1;<sub>4</sub>&#x003b2;<sub>3</sub>, and CD11b/CD18 <xref ref-type="bibr" rid="ppat.1000687-Cinco1">&#x0005b;65&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Behera2">&#x0005b;70&#x0005d;</xref>, and the cytosolic adapter protein MyD88 <xref ref-type="bibr" rid="ppat.1000687-Shin1">&#x0005b;64&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Liu2">&#x0005b;71&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Shin2">&#x0005b;72&#x0005d;</xref>. A report that CD14 acts as a unique phagocytic receptor for Gram-negative bacteria <xref ref-type="bibr" rid="ppat.1000687-Schiff1">&#x0005b;73&#x0005d;</xref>, suggested that this molecule might serve a similar function in spirochetal uptake. However, we found that CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were equally adept at binding and internalizing <italic>B. burgdorferi</italic>. As such, a Phagocytic Receptor &#x0201c;Y&#x0201d; (<xref ref-type="fig" rid="ppat-1000687-g007">Figure 7B</xref>) of unknown identity acts in tandem with/without CD14 to concomitantly initiate spirochetal uptake and innate immune signaling in a TLR2-dependent and -independent fashion. Importantly, live spirochetes versus lysates appear to exhibit a differential capacity to engage Phagocytic Receptor &#x0201c;Y&#x0201d; which underlies why equivalent amounts of each stimulus elicit different amounts of cytokine <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Olson1">&#x0005b;22&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Cruz1">&#x0005b;42&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Moore1">&#x0005b;43&#x0005d;</xref>, and perhaps why p38 plays a dichotomous role in regulating the TNF-&#x003b1; production described herein. Despite similar spirochetal uptake, greater recovery of bacteria from infected CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; and mice suggested differential killing of <italic>B. burgdorferi</italic> in the presence or absence of CD14. Bacterial killing within M&#x003a6; occurs by two principal means: i) the generation of RNS/ROS which reduces phagosomal pH thus facilitating their fusion with lysosomes and ii) the production of antimicrobial peptides <xref ref-type="bibr" rid="ppat.1000687-Flannagan1">&#x0005b;35&#x0005d;</xref>. Several recent <italic>in vitro</italic> studies demonstrate the susceptibility of <italic>B. burgdorferi</italic> to RNS/ROS <xref ref-type="bibr" rid="ppat.1000687-Pancewicz1">&#x0005b;74&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Boylan2">&#x0005b;77&#x0005d;</xref>. Additionally, <italic>in vivo</italic> studies have shown that RNAi suppression of tick salivary proteins capable of neutralizing RNS/ROS at the vector-host-pathogen interface increase the survival of spirochetes in skin and facilitate their dissemination throughout the host <xref ref-type="bibr" rid="ppat.1000687-Anderson1">&#x0005b;78&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Guo1">&#x0005b;80&#x0005d;</xref>. Consistent with this latter finding the higher bacterial burden observed in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; and mice is associated with lower <italic>in vitro</italic> and <italic>in vivo</italic> transcription of <italic>inos</italic>. Release of antimicrobial peptides by human M&#x003a6; is triggered by p38-dependent vitamin D<sub>3</sub> receptor (VDR) signaling <xref ref-type="bibr" rid="ppat.1000687-Liu3">&#x0005b;81&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Adams1">&#x0005b;85&#x0005d;</xref>; however, whether the same regulatory network exists in mouse M&#x003a6; is unclear. Interestingly, transcription of <italic>vdr</italic> was dramatically lower in CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; than in their wild type counterparts (data not shown). Thus differential transcription of <italic>inos</italic> and <italic>vdr</italic> may explain, at least in part, the impaired ability of CD14<sup>&#x02212;/&#x02212;</sup> mice to clear spirochetes from infected organs. Differential transcription of <italic>inos</italic>, <italic>vdr</italic>, <italic>socs</italic>, and phosphorylation of STAT1 suggest the involvement of p38-MAPK, which controls all these events in M&#x003a6;.</p><p>AKT has pleiotropic effects that include promotion of cell survival, NF-&#x003ba;B activation, and inhibition of ASK1, a MAPKKK responsible for p38 activity <xref ref-type="bibr" rid="ppat.1000687-Gratton1">&#x0005b;44&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Kim2">&#x0005b;45&#x0005d;</xref>. p38 activity is associated with NF-&#x003ba;B activation and stabilization of mRNA encoding proinflammatory cytokines such as TNF-&#x003b1; <xref ref-type="bibr" rid="ppat.1000687-Dean1">&#x0005b;23&#x0005d;</xref>. The observation that inhibition of PI3K prevented phosphorylation of AKT and thus increased p38 activity in <italic>B. burgdorferi</italic>-activated CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; is consistent with the inverse relationship between AKT and p38 activity <xref ref-type="bibr" rid="ppat.1000687-Gratton1">&#x0005b;44&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Kim2">&#x0005b;45&#x0005d;</xref>. Unexpectedly, PI3K inhibition also resulted in decreased TNF-&#x003b1; production, a finding inconsistent with higher p38 activity and its &#x0201c;accepted&#x0201d; role as a proinflammatory mediator <xref ref-type="bibr" rid="ppat.1000687-Schieven1">&#x0005b;20&#x0005d;</xref>. Nevertheless, also consistent with our finding, direct inhibition of p38 in <italic>B. burgdorferi</italic>-stimulated CD14<sup>&#x0002b;/&#x0002b;</sup> cells with either general or specific antagonists resulted in lower <italic>inos</italic> and <italic>socs3</italic> transcription and a dose-dependent increase in TNF-&#x003b1;. This provocative finding was further supported by the ability of shRNA to suppress CD14 expression in M&#x003a6; thereby reducing phosphorylation of p38 and increasing TNF-&#x003b1; release in response to spirochetes. Finally, in a murine model of Lyme borreliosis transient inhibition of p38 through use of inhibitors was found to increase <italic>B. burgdorferi</italic>-induced carditis and is associated with a higher bacterial burden in infected tissues &#x0005b;personal communication; Dr. Juan Anguita, Ph.D., (Veterinary &#x00026; Animal Sciences, University of Massachusetts, Amherst)&#x0005d;. This altered disease phenotype is reminiscent of the increased histopathology and higher bacterial burden in the infected tissues of CD14<sup>&#x02212;/&#x02212;</sup> mice whose M&#x003a6; only transiently produce active p38 following activation by <italic>B. burgdorferi</italic>.</p><p>Contrarily, p38 inhibition reduces TNF-&#x003b1; secretion by the mouse RAW264.7M&#x003a6; cell line in response to borrelial lysates <xref ref-type="bibr" rid="ppat.1000687-Olson1">&#x0005b;22&#x0005d;</xref>. We too report that inhibition of p38 in CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; reduced TNF-&#x003b1; production in response to borrelial lysates, but not live spirochetes, and did so in a dose-dependent fashion. One potential explanation for the contradictory finding that p38 inhibition augments the inflammatory response to live bacteria and suppresses the response to lysates is that the context in which bacterial DAMPs are recognized influences the downstream signaling cascades initiated within the host cell. Supportive of this idea, several studies have demonstrated that live versus lysed spirochetes (wherein molar equivalency of the two stimuli is established) elicits a differential cytokine response from M&#x003a6; of mouse and human origin <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Cruz1">&#x0005b;42&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Moore1">&#x0005b;43&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Salazar1">&#x0005b;86&#x0005d;</xref>. The anti-inflammatory capacity of p38 is further demonstrated in mouse models of pneumococcal pneumonia and tuberculosis where its inhibition results in impaired bacterial clearance and increased TNF-&#x003b1; production both <italic>in vitro</italic> and <italic>in vivo</italic><xref ref-type="bibr" rid="ppat.1000687-vandenBlink1">&#x0005b;87&#x0005d;</xref>. It also has been established that p38 induces the shedding of TNF receptor-1 from activated cells thus dampening their responsiveness to TNF-&#x003b1; <xref ref-type="bibr" rid="ppat.1000687-Ogura1">&#x0005b;88&#x0005d;</xref>. The combination of increased TNF-&#x003b1; production and maintenance of its cognate receptor on the cell surface likely contributes to the cytokine &#x0201c;surge&#x0201d; and exacerbates the pathology associated with bacterial infection. Taken together, these results challenge the notion that disaggregated or isolated DAMPs (<italic>e.g.</italic>, lysates, purified LPS, lipoproteins, <italic>etc.</italic>) are equivalent to the whole organisms from which they are generated <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Ropert1">&#x0005b;24&#x0005d;</xref>. They also sound a cautionary note regarding application of p38 inhibitors to treat inflammatory disorders, especially those of infectious origin, wherein blockade of this signaling pathway may exacerbate rather than ablate inflammation. Development of immunotherapeutic strategies that enhance the action of SOCS may represent a more fruitful avenue in pursuit of novel anti-inflammatory drugs <xref ref-type="bibr" rid="ppat.1000687-Croker1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="ppat.1000687-Egan1">&#x0005b;89&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Shouda1">&#x0005b;91&#x0005d;</xref>. Despite the concordance of results described above it also must be acknowledged that commonly used inhibitors of PI3K and p38 demonstrate off-target effects including blockade of other kinases and phagocytosis when used at high concentrations. In the present study, the use of inhibitors at low concentrations partially mitigates the likelihood of such off-target effects, however, left unclear is their potential impact on phagocytosis of <italic>B. burgdorferi</italic> and subsequent cytokine release by host cells. Further complicating this issue is the existence of eight isoforms of PI3K and four isoforms of p38. The relative contribution of different isoforms to activation of host cells and the influence of exposure to live versus lysed spirochetes on signaling are currently under investigation employing a shRNA strategy that will obviate concerns raised by non-specificity.</p><p>A correlative relationship exists between phagocytosis of bacteria and cytokine release <xref ref-type="bibr" rid="ppat.1000687-Murray1">&#x0005b;92&#x0005d;</xref>. For example, MyD88 deficiency impairs both uptake of <italic>B. burgdorferi</italic> by mouse M&#x003a6; and subsequent transcription of <italic>tnf&#x003b1;</italic> and <italic>il6</italic><xref ref-type="bibr" rid="ppat.1000687-Shin2">&#x0005b;72&#x0005d;</xref>. Under other circumstances (<italic>i.e.</italic>, TLR2 deficiency), while uptake of spirochetes by M&#x003a6; was unaffected, the transcription of a variety of cytokine and chemokine genes was significantly reduced <xref ref-type="bibr" rid="ppat.1000687-Shin2">&#x0005b;72&#x0005d;</xref>. Similarly, we found that CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were equally adept at binding and internalizing <italic>B. burgdorferi</italic> and cytokine secretion was altered; however, in this case, the proinflammatory response of M&#x003a6; lacking CD14 was significantly greater than that seen with their wild-type counterparts. Differences in TNF-&#x003b1; levels might simply reflect the greater survival/persistence of spirochetes within and expression of TLR2 by CD14<sup>&#x02212;/&#x02212;</sup> versus CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6;, either or both of which could potentiate cytokine secretion. However, evidence provided by <italic>in vivo</italic> experiments argues against cytokine secretion being directly linked to spirochetal burden insofar as higher cytokine levels in the serum of CD14<sup>&#x02212;/&#x02212;</sup> mice at 1 and 3 week p.i. (<xref ref-type="supplementary-material" rid="ppat.1000687.s002">Figure S2</xref>) precedes the significant differences in bacterial burden observed at 6 weeks (<xref ref-type="supplementary-material" rid="ppat.1000687.s003">Table S1</xref>). We propose that the aforementioned response is more likely a reflection of the inability of <italic>B. burgdorferi</italic> to induce tolerance in M&#x003a6; lacking CD14 which, in turn, results from impaired p38-mediated SOCS activity. Trace amounts of DAMPs can impose tolerance on M&#x003a6; thus making them less or unresponsive following subsequent reexposure to stimuli of an identical or similar (cross-tolerization) nature <xref ref-type="bibr" rid="ppat.1000687-Albrecht1">&#x0005b;93&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000687-Orio1">&#x0005b;94&#x0005d;</xref>. Relevant to the phenomenon of tolerance, Dennis <italic>et al.</italic> reported that recognition of <italic>B. burgdorferi</italic> activates SOCS <xref ref-type="bibr" rid="ppat.1000687-Dennis1">&#x0005b;95&#x0005d;</xref> and Diterich <italic>et al.</italic> showed that <italic>B. burgdorferi</italic> can tolerize M&#x003a6; <xref ref-type="bibr" rid="ppat.1000687-Diterich1">&#x0005b;96&#x0005d;</xref> and induction of tolerance requires p38-mediated stimulation of SOCS <xref ref-type="bibr" rid="ppat.1000687-Ropert1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="ppat.1000687-Foster1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="ppat.1000687-Bode2">&#x0005b;97&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000687-Nakagawa1">&#x0005b;101&#x0005d;</xref>. Here we mechanistically link these previous findings by showing that CD14 recognition of <italic>B. burgdorferi</italic> triggers p38-dependent SOCS activity to impose a tolerant phenotype within M&#x003a6;. Interestingly, this CD14-dependent mechanism of tolerance may be operative in the absence of TLR2 as well, a notion supported by the observation that TLR2<sup>&#x02212;/&#x02212;</sup> M&#x003a6; produce significantly less cytokine than when these cells also are deficient for CD14. Uncontrolled release of proinflammatory cytokines by cells lacking CD14 likely is further exacerbated by their diminished production of the anti-inflammatory cytokine IL-10, which normally would temper such responses (data not shown). Thus, activation of M&#x003a6; in the absence of CD14 may represent the &#x0201c;perfect storm&#x0201d; of increased bacterial burden and expression of TLR2 and reduced tolerance to perpetual stimulation by <italic>B. burgdorferi</italic>. It is this dysregulated response at the cellular level which underpins the altered Lyme disease phenotype observed in CD14<sup>&#x02212;/&#x02212;</sup> mice.</p><p><italic>In toto</italic>, we detail a critical and unanticipated role for CD14 in downmodulating TLR2-dependent and -independent pathways which regulate NF-&#x003ba;B signaling events. We provide evidence that reduced SOCS activity licenses greater cytokine production through diminished negative regulation of the TLR2 pathway. CD14 exerts its influence on the intensity and duration of inflammation through the PI3K/AKT/p38-MAPK axis which serves as a &#x0201c;rheostat&#x0201d; to finely modulate NF-&#x003ba;B activity, a critical regulator of the host's inflammatory response to pathogenic challenge. An intriguing question raised by these findings is whether individual differences in the clinical course of infection might reflect the susceptibility of the patient's innate immune system to tolerization.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4a"><title>Reagents</title><p>All buffers and reagents were prepared to minimize contamination with environmental LPS by utilizing baked (180&#x000b0;C for 4 h) and autoclaved glassware, disposable plasticware, and pyrogen-free H<sub>2</sub>O.</p></sec><sec id="s4b"><title>Cultivation of <italic>B. burgdorferi</italic></title><p>Low-passage <italic>B. burgdorferi</italic> strain 297 were maintained at 23&#x000b0;C in Barbour-Stoenner-Kelley medium containing 6&#x00025; normal rabbit serum (BSK<sub>complete</sub>) from Pel-Freez Biologicals (Rogers, AR) and then temperature-shifted to 37&#x000b0;C. Increased expression of OspC was confirmed by silver staining of whole borrelial lysates separated by SDS-PAGE. <italic>B. burgdorferi</italic> 297 expressing green fluorescent protein were cultivated in BSK<sub>complete</sub> containing 400 &#x000b5;g/ml kanamycin and were grown at 37&#x000b0;C until mid- to late-logarithmic phase for subsequent use in phagocytosis experiments as previously described <xref ref-type="bibr" rid="ppat.1000687-Eggers1">&#x0005b;102&#x0005d;</xref>. For the generation of borrelial lysates temperature shifted bacteria were harvested by centrifugation at 8000&#x000d7;<italic>g</italic>, washed twice with PBS lacking Ca<sup>&#x0002b;&#x0002b;</sup> and Mg<sup>&#x0002b;&#x0002b;</sup>, and finally resuspended in PBS. Lysates were prepared by sonicating the bacteria for 30 s (with three separate 10 s pulses at 30 s intervals) using a 60-Dismembrator (Fisher Scientific, Waltham, MA). The total protein content of lysates was determined using the BCA method.</p></sec><sec id="s4c"><title>Mice and infection protocol</title><p>Four to eight week-old C3H/HeN (CD14<sup>&#x0002b;/&#x0002b;</sup>) mice (Taconic, Germantown, NY) were housed in the Animal Resources Facility at Albany Medical College. Food and water were provided <italic>ad libitum</italic> and all animal procedures were approved by the Institutional Animal Care and Use Committee of Albany Medical College. CD14<sup>&#x02212;/&#x02212;</sup> mice were generated as previously described <xref ref-type="bibr" rid="ppat.1000687-Haziot1">&#x0005b;6&#x0005d;</xref> and subsequently backcrossed 10 generations onto a C3H/HeN background <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>. TLR2<sup>&#x02212;/&#x02212;</sup> mice were provided by Tularik Inc. (now Amgen Inc., South San Francisco, CA), generated by Deltagen Inc. (Menlo Park, CA) <xref ref-type="bibr" rid="ppat.1000687-Werts1">&#x0005b;103&#x0005d;</xref> and were backcrossed 10 generations onto a C3H/HeN background. C3H/HeN mice deficient for CD14 and TLR2 were crossed to establish animals that are homozygous recessive for both alleles.</p><p>Mice were infected via intradermal administration of 1&#x000d7;10<sup>5</sup> spirochetes over the sternum. For some experiments mice were infected using <italic>Ixodes scapularis</italic> ticks carrying <italic>B. burgdorferi</italic> as previously described <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>. At one week intervals, tibiotarsal joint thickness was measured using digital calipers and bacterial burden in infected tissues was determined using isolated genomic DNA as previously described <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>. Total RNA also was isolated from infected tissues for qPCR as described below.</p></sec><sec id="s4d"><title>Isolation and differentiation of M&#x003a6;</title><p>M&#x003a6; were isolated from the bone marrow of six to eight week-old mice. Briefly, bone marrow cells recovered by flushing femurs and tibia with DMEM were incubated in tissue culture-treated 25cm<sup>2</sup>-flasks (BD Falcon, BD Biosciences, San Jose, CA) overnight at 37&#x000b0;C with 5&#x00025; CO<sub>2</sub> to eliminate adherent fibroblasts, granulocytes, and any contaminating M&#x003a6; <xref ref-type="bibr" rid="ppat.1000687-Warren1">&#x0005b;104&#x0005d;</xref>. The following day, 1&#x000d7;10<sup>7</sup> suspension cells were maintained in 10-cm<sup>2</sup> bacteriological Petri dishes (BD-Falcon) for three days with DMEM supplemented with 10&#x00025; fetal bovine serum, 20&#x00025; L292-cell conditioned media, 0.01&#x00025; HEPES, 0.01&#x00025; sodium pyruvate, and 0.01&#x00025; L-glutamine. Cultures were supplemented with 5 ml of the above-described medium and seven days after isolation cell monolayers were recovered using ice-cold PBS and scraping. Single cell suspensions were used immediately or frozen in liquid nitrogen with 20&#x00025; FBS and 10&#x00025; DMSO for use in future experiments.</p></sec><sec id="s4e"><title><italic>B. burgdorferi</italic>-M&#x003a6; co-incubation</title><p>M&#x003a6; were seeded into 6-well tissue culture-treated plates at a concentration of 1&#x000d7;10<sup>6</sup> cells/2 ml/well and allowed to adhere overnight. The following day, <italic>B. burgdorferi</italic> were enumerated and resuspended as described above. M&#x003a6; were washed twice with serum-free DMEM to remove any traces of FBS and spirochetes (resuspended in DMEM &#x0002b; 4&#x00025; autologous serum) were added at a MOI of 10 and co-incubated for different time intervals at 37&#x000b0;C in 5&#x00025; CO<sub>2</sub>. Cells incubated with DMEM &#x0002b; 4&#x00025; autologous serum alone served as mock-infected controls. For tolerance experiments, M&#x003a6; were initially incubated with <italic>B. burgdorferi</italic> at a MOI of 10 for 12 h at 37&#x000b0;C in 5&#x00025; CO<sub>2</sub>. Supernatants were collected to determine TNF-&#x003b1; levels by CBA and cells were washed extensively with pre-warmed serum-free medium before addition of fresh medium containing <italic>B. burgdorferi</italic> at the same concentration as used for the primary exposure. Supernatants were collected after an additional 6 h of co-culture and TNF-&#x003b1; levels were again measured.</p></sec><sec id="s4f"><title>Quantitative real-time PCR</title><p>Total RNA was isolated from M&#x003a6; using the RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany) as per the manufacturer. The amount and purity of RNA was quantified by Biophotometer (Eppendorf AG, Hamburg, Germany) and 0.5&#x000b5;g were used for reverse transcription of cDNA using Superscript II (Invitrogen Corporation, Carlsbad, CA). cDNA (20&#x000b5;l) served as the template in quantitative real-time PCR (qPCR) analysis using Mouse TLR Signaling Pathway RT<sup>2</sup> Profiler&#x02122; PCR Arrays (SABiosciences, Frederick, MD). This qPCR methodology directly quantifies transcript levels based upon the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method through measurement of SYBR green fluorescence using an iQ5 real-time PCR detection system (Bio-Rad Laboratories, Hercules, CA).</p><p>For transcriptional analysis of genes not represented on the RT<sup>2</sup> Profiler&#x02122; PCR Array, unique genes were interrogated by qPCR in a final volume of 25 &#x000b5;l containing: 12.5 &#x000b5;l of 2&#x000d7; SYBR green master mix (Bio-Rad Laboratories), 25 pico-moles of forward and reverse primers, and 0.2 &#x000b5;l of cDNA. Primers were designed using Beacon Designer version 7.0 software (PREMIER Biosoft Intl, Palo Alto, CA) and the sequences of specific primer sets are provided in <xref ref-type="supplementary-material" rid="ppat.1000687.s004">Table S2</xref>. Amplification conditions were 95&#x000b0;C (3 min) and 40 cycles of 95&#x000b0;C (15 s), 55&#x000b0;C (40 s) and 72&#x000b0;C (30 s). All the qPCR reactions were run in triplicate with no-template controls (NTC) and mean c<italic>T</italic> values were used for all the calculations using 18S rRNA as an internal normalization control. Transcript levels for infected groups are presented as a fold change over their corresponding uninfected control group. A greater than two-fold change with respect to mock control was considered significant.</p></sec><sec id="s4g"><title>Western blot analysis</title><p>Antibodies directed against SOCS1, SOCS3 and CIS were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), antibodies against AKT, STAT1, STAT3 and p38 were obtained from Cell Signaling Technology, Inc. (Danvers, MA), and antibodies against &#x003b2;-actin were obtained from Bethyl Laboratories, Inc. (Montgomery, TX). Protein samples (25&#x02013;100&#x000b5;g, depending on the target) were resolved by SDS-PAGE and transferred to nitrocellulose using semi-dry transblot (Bio-Rad Laboratories, Hercules, CA). The membrane was blocked with 5&#x00025; non-fat milk and then incubated overnight at 4&#x000b0;C with primary antibody (1&#x02236;1000 for AKT and STATs, 1&#x02236;100 for SOCS, and 1&#x02236;10,000 for &#x003b2;-actin). Membranes were probed with HRP-conjugated anti-rabbit IgG (Cell Signaling Technology) diluted 1&#x02236;2000. Specific signal was developed using the SuperSignal West-Dura chemiluminescent substrate (Pierce Endogen, Rockford, IL).</p></sec><sec id="s4h"><title>Cytometric bead array (CBA) for cytokine and phospho-protein analysis</title><p>Cytokine levels were measured in recovered culture supernatant using the Mouse Inflammation CBA kit and a FACSArray flow cytometer &#x0005b;BD Immunocytometry Systems (BDIS), San Jose, CA&#x0005d;. Data was acquired and analyzed using BD FACSArray software and FCAP Array software, version 1.0 (BDIS), respectively. For phospho-protein analysis, the protein content of the samples was normalized, and samples were analyzed using a phospho-specific CBA kit.</p></sec><sec id="s4i"><title>Determination of recoverable live <italic>B. burgdorferi</italic> from M&#x003a6;</title><p>To enumerate <italic>B. burgdorferi</italic> recovered from CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; we used a variation on the classical tissue culture infective dose (TCID) method used in virology to determine the viral titer necessary to infect 50&#x00025; of target cells. Briefly, 5&#x000d7;10<sup>4</sup> CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; were co-incubated for 6 h with <italic>B. burgdorferi</italic> at a MOI of 10. The M&#x003a6; were washed with PBS lacking Ca<sup>&#x0002b;&#x0002b;</sup> and Mg<sup>&#x0002b;&#x0002b;</sup> and the cells were harvested by scraping. Ten-fold serial dilutions were made in BSK<sub>complete</sub> media down to 10<sup>&#x02212;7</sup>. Aliquots of 100&#x000b5;l of each dilution were placed in triplicate wells of a 96-well microtiter plate and incubated for 7 days. On the 7<sup>th</sup> day dark field microscopy was used to visualize spirochetes and bacterial titers were calculated using the Reed-Muench formula <xref ref-type="bibr" rid="ppat.1000687-Reed1">&#x0005b;105&#x0005d;</xref>.</p></sec><sec id="s4j"><title>Inhibition of signaling cascades by pharmacological inhibitors</title><p>M&#x003a6; were treated with the inhibitors arctigenin (1&#x000b5;M), SB202190 (0.5&#x000b5;M), SB203580 (10&#x000b5;M), wortmannin (100nM), and Ly294002 (100&#x000b5;M) for 30 min prior to addition of <italic>B. burgdorferi</italic> at a MOI of 10. In some experiments a range of inhibitor concentrations was used. DMSO alone served as a control. Culture supernatants were collected for cytokine measurement and cells were lysed for RNA isolation and Western blot analysis.</p></sec><sec id="s4k"><title>Lipid raft isolation</title><p>M&#x003a6; (1&#x000d7;10<sup>7</sup>) from CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> mice were lysed after 5 min exposure to <italic>B. burgdorferi</italic> at a MOI of 10 using ice-cold TNE buffer &#x0005b;10mM Tris (pH 7.5), 150mM NaCl and 5mM EDTA&#x0005d; containing 1&#x00025; Triton X-100. Lysates were centrifuged at 48,000&#x000d7;<italic>g</italic> for 4 h on a sucrose gradient to float the lipid raft fraction from the non-raft fraction. Fractions (40 &#x000b5;l) were resolved by SDS-PAGE and analyzed by Western blotting as described above. Antibodies used at the manufacturer's suggested concentrations included rabbit anti-mouse PI3K (Santa Cruz Biotechnology), flotillin-1 (Cell Signaling Technology), and &#x003b2;-actin (Bethyl Laboratories).</p></sec><sec id="s4l"><title>Two-photon laser confocal microscopy</title><p>M&#x003a6; were seeded into 8-well chamber slides (Lab-Tek&#x02122; II CC2 Chamber Slide&#x02122; System) at a concentration of 1&#x000d7;10<sup>5</sup> cells/200&#x000b5;l/well and allowed to adhere overnight. The following day, after staining the cell membrane using wheat germ agglutinin Alexa Fluor-647, GFP-expressing <italic>B. burgdorferi</italic> were enumerated and added to cell monolayers at a MOI of 100 and co-incubated for different time intervals. The cells were fixed with 1&#x00025; paraformaldehyde and were mounted in VECTASHIELD&#x000ae; with DAPI (Reactolab SA, Servion, Switzerland). Confocal images were acquired using a Zeiss LSM-510 META-NLO microscope equipped with argon and HeNe lasers. Optically sectioned images were acquired using a 40&#x000d7; objective (512&#x000d7;512 pixel resolution) at 0.5 &#x000b5;m intervals. Image processing and analysis were performed using ImageJ (NIH, v1.41b) and LSM Image Browser (Zeiss, v5.0). Depth coding and green color extraction was used to determine the area representing internalized GFP-labeled <italic>B. burgdorferi</italic>. The hue/saturation was brought up to 100&#x00025; in Adobe Photoshop and the green color was extracted, imported into ImageJ and the percentage of green area was measured.</p></sec><sec id="s4m"><title>FACS analysis</title><p>M&#x003a6; (5&#x000d7;10<sup>5</sup> cells) were aliquoted into 5 ml polystyrene round-bottom tubes (BD Biosciences, Bedford, MA) and incubated with GFP-expressing <italic>B. burgdorferi</italic> resuspended in DMEM&#x0002b;4&#x00025; autologous serum at a MOI of 10. Cells and bacteria were co-incubated for different time intervals at 4&#x000b0;C or 37&#x000b0;C and then processed for flow cytometric analysis as previously described <xref ref-type="bibr" rid="ppat.1000687-Benhnia1">&#x0005b;10&#x0005d;</xref>. Phagocytic indices were calculated using the formula phagocytic index&#x0200a;&#x0003d;&#x0200a;(&#x00025; GFP<sup>&#x0002b;</sup> cells at 37&#x000b0;C&#x000d7;MFI at 37&#x000b0;C)&#x02212;(&#x00025; GFP<sup>&#x0002b;</sup> at 4&#x000b0;C&#x000d7;MFI at 4&#x000b0;C).</p></sec><sec id="s4n"><title>Lentiviral transduction</title><p>Knock down of CD14 was achieved using a pRS-shGFP lentiviral expression vector (OriGene Technologies, Rockville, MD) to transduce either a CD14 shRNA or a scrambled control shRNA into CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6;. Briefly, ampho packaging cell lines (Orbigen Inc., San Diego, CA) were transfected with lentiviral vector expressing scrambled shRNA or shRNA targeting CD14 using a standard calcium phosphate method. Cell-culture supernatants were collected 48 h post-transfection and titered virus was added to CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; in presence of 4&#x000b5;g/ml Polybrene. The efficiency of suppression of CD14 was assessed 72 h post-viral transduction using flow cytometry and Western blot analysis.</p></sec><sec id="s4o"><title>Statistical analysis</title><p>A two-way Analysis of Variance (ANOVA) followed by a Fisher LSD post-hoc test (InStat 4.0, GraphPad Software Inc., La Jolla, CA) was used to analyze data presented in <xref ref-type="fig" rid="ppat-1000687-g002">Figure 2A</xref>. Other data sets were analyzed for statistical significance using a parametric two-way ANOVA with a Bonferroni correction if the data was found to fit a Gaussian distribution (tested using the method Kolmogorov and Smirnov). When not normally distributed the data was analyzed for statistical significance using a non-parametric two-way ANOVA with Mann&#x02013;Whitney U test. An &#x003b1;&#x0200a;&#x0003d;&#x0200a;0.05 level was used to determine whether a significant difference existed between data from CD14<sup>&#x0002b;/&#x0002b;</sup> versus CD14<sup>&#x02212;/&#x02212;</sup> and untreated versus treated groups.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="ppat.1000687.s001"><label>Figure S1</label><caption><p>CD14 deficiency undermines the Lyme arthritis-resistant phenotype of C57BL/6 mice. CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> C57BL/6 mice were infected using <italic>Ixodes scapularis</italic> ticks carrying <italic>B. burgdorferi</italic> and tibiotarsal joint thickness was measured at 1-wk intervals using digital calipers. The horizontal bars indicate mean thickness for each group and the data are representative of two independent experiments (n&#x0200a;&#x0003d;&#x0200a;24).</p><p>(0.56 MB TIF)</p></caption><media xlink:href="ppat.1000687.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1000687.s002"><label>Figure S2</label><caption><p>CD14 deficiency results in increased <italic>in vivo</italic> cytokine production in response to <italic>B. burgdorferi</italic>. CD14<sup>&#x0002b;/&#x0002b;</sup> and CD14<sup>&#x02212;/&#x02212;</sup> C57BL/6 mice were tick-inoculated with <italic>B. burgdorferi</italic> and serum cytokine levels were measured using CBA at 1, 3, and 6 wks p.i.. Results represent mean&#x000b1;SEM from three independent experiments. &#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.01, &#x0002a;&#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.001.</p><p>(0.22 MB TIF)</p></caption><media xlink:href="ppat.1000687.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1000687.s003"><label>Table S1</label><caption><p>CD14 deficiency impairs clearance of <italic>B. burgdorferi</italic> in C57BL/6 mice. Mice were sacrificed at 1, 3, and 6 wks post tick-inoculation and DNA was isolated from the indicated tissues for qPCR analysis as described in <xref ref-type="fig" rid="ppat-1000687-g002">Figure 2C</xref> and <xref ref-type="sec" rid="s4">Methods</xref>. Results represent mean&#x000b1;SEM from three independent experiments (n&#x0200a;&#x0003d;&#x0200a;10 to 16) wherein samples were run in triplicate. &#x0002a;<italic>P</italic>&#x0003c;0.05, &#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.01.</p><p>(0.10 MB PDF)</p></caption><media xlink:href="ppat.1000687.s003.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1000687.s004"><label>Table S2</label><caption><p>Primer sequences used in qPCR.</p><p>(0.10 MB PDF)</p></caption><media xlink:href="ppat.1000687.s004.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1000687.s005"><label>Video S1</label><caption><p>Movie sequence of stacked optical z section of CD14<sup>&#x0002b;/&#x0002b;</sup> M&#x003a6; shown in <xref ref-type="fig" rid="ppat-1000687-g003">Figure 3C</xref>.</p><p>(7.30 MB MOV)</p></caption><media xlink:href="ppat.1000687.s005.mov" mimetype="video" mime-subtype="quicktime"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1000687.s006"><label>Video S2</label><caption><p>Movie sequence of stacked optical z section of CD14<sup>&#x02212;/&#x02212;</sup> M&#x003a6; shown in <xref ref-type="fig" rid="ppat-1000687-g003">Figure 3C</xref>.</p><p>(6.50 MB MOV)</p></caption><media xlink:href="ppat.1000687.s006.mov" mimetype="video" mime-subtype="quicktime"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Drs. James Drake, Jonathan Harton, Karsten Hazlett (Albany Medical College, NY), Juan Anguita (University of Massachusetts, Amherst, MA), and Kathleen McCabe for critical review of the manuscript. We also thank Dr. James Drake for his help in the isolation and subsequent analysis of lipid rafts. Special thanks to Aaloki Shah and Sally Catlett (Albany Medical College, NY) for technical support and Daniel Desrosiers (University of Connecticut Health Science Center, CT) for computer graphic design. We thank Dr. Star Duhnam-Ems and Carson La Vake (University of Connecticut Health Science Center, CT) and Dr. Joseph Mazurkiewicz (Albany Medical Center Imaging Core, Albany Medical College) for confocal assistance using the Zeiss LSM-510 META-NLO two-photon laser confocal microscope.</p></ack><ref-list><title>References</title><ref id="ppat.1000687-Wooten1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname><given-names>RM</given-names></name><name><surname>Weis</surname><given-names>JJ</given-names></name></person-group><year>2001</year><article-title>Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes.</article-title><source>Curr Opin Microbiol</source><volume>4</volume><fpage>274</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">11378478</pub-id></mixed-citation></ref><ref id="ppat.1000687-Arbibe1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbibe</surname><given-names>L</given-names></name><name><surname>Mira</surname><given-names>JP</given-names></name><name><surname>Teusch</surname><given-names>N</given-names></name><name><surname>Kline</surname><given-names>L</given-names></name><name><surname>Guha</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Toll-like receptor 2-mediated NF-&#x0005b;kappa&#x0005d;B activation requires a Rac1-dependent pathway.</article-title><source>Nat Immunol</source><volume>1</volume><fpage>533</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">11101877</pub-id></mixed-citation></ref><ref id="ppat.1000687-Steere1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steere</surname><given-names>AC</given-names></name><name><surname>Glickstein</surname><given-names>L</given-names></name></person-group><year>2004</year><article-title>Elucidation of Lyme arthritis.</article-title><source>Nat Rev Immunol</source><volume>4</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">15040587</pub-id></mixed-citation></ref><ref id="ppat.1000687-Antal1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antal</surname><given-names>S</given-names></name></person-group><year>2000</year><article-title>Evaluation of CD14 in host defence.</article-title><source>European Journal of Clinical Investigation</source><volume>30</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">10651843</pub-id></mixed-citation></ref><ref id="ppat.1000687-Sellati1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellati</surname><given-names>TJ</given-names></name><name><surname>Bouis</surname><given-names>DA</given-names></name><name><surname>Kitchens</surname><given-names>RL</given-names></name><name><surname>Darveau</surname><given-names>RP</given-names></name><name><surname>Pugin</surname><given-names>J</given-names></name><etal/></person-group><year>1998</year><article-title>Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide.</article-title><source>J Immunol</source><volume>160</volume><fpage>5455</fpage><lpage>5464</lpage><pub-id pub-id-type="pmid">9605148</pub-id></mixed-citation></ref><ref id="ppat.1000687-Haziot1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haziot</surname><given-names>A</given-names></name><name><surname>Ferrero</surname><given-names>E</given-names></name><name><surname>Kontgen</surname><given-names>F</given-names></name><name><surname>Hijiya</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><etal/></person-group><year>1996</year><article-title>Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice.</article-title><source>Immunity</source><volume>4</volume><fpage>407</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">8612135</pub-id></mixed-citation></ref><ref id="ppat.1000687-Gangloff1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangloff</surname><given-names>SC</given-names></name><name><surname>Zahringer</surname><given-names>U</given-names></name><name><surname>Blondin</surname><given-names>C</given-names></name><name><surname>Guenounou</surname><given-names>M</given-names></name><name><surname>Silver</surname><given-names>J</given-names></name><etal/></person-group><year>2005</year><article-title>Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex.</article-title><source>J Immunol</source><volume>175</volume><fpage>3940</fpage><lpage>3945</lpage><pub-id pub-id-type="pmid">16148141</pub-id></mixed-citation></ref><ref id="ppat.1000687-Jiang1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Georgel</surname><given-names>P</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Shamel</surname><given-names>L</given-names></name><name><surname>Sovath</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>CD14 is required for MyD88-independent LPS signaling.</article-title><source>Nat Immunol</source><volume>6</volume><fpage>565</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">15895089</pub-id></mixed-citation></ref><ref id="ppat.1000687-Han1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Bibbs</surname><given-names>L</given-names></name><name><surname>Ulevitch</surname><given-names>RJ</given-names></name></person-group><year>1994</year><article-title>A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.</article-title><source>Science</source><volume>265</volume><fpage>808</fpage><lpage>811</lpage><pub-id pub-id-type="pmid">7914033</pub-id></mixed-citation></ref><ref id="ppat.1000687-Benhnia1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benhnia</surname><given-names>MR</given-names></name><name><surname>Wroblewski</surname><given-names>D</given-names></name><name><surname>Akhtar</surname><given-names>MN</given-names></name><name><surname>Patel</surname><given-names>RA</given-names></name><name><surname>Lavezzi</surname><given-names>W</given-names></name><etal/></person-group><year>2005</year><article-title>Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease.</article-title><source>J Immunol</source><volume>174</volume><fpage>1539</fpage><lpage>1548</lpage><pub-id pub-id-type="pmid">15661914</pub-id></mixed-citation></ref><ref id="ppat.1000687-Schroeder1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>R</given-names></name><name><surname>London</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name></person-group><year>1994</year><article-title>Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior.</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>91</volume><fpage>12130</fpage><lpage>12134</lpage><pub-id pub-id-type="pmid">7991596</pub-id></mixed-citation></ref><ref id="ppat.1000687-Lafont1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafont</surname><given-names>F</given-names></name><name><surname>Abrami</surname><given-names>L</given-names></name><name><surname>van der Goot</surname><given-names>FG</given-names></name></person-group><year>2004</year><article-title>Bacterial subversion of lipid rafts.</article-title><source>Curr Opin Microbiol</source><volume>7</volume><fpage>4</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">15036133</pub-id></mixed-citation></ref><ref id="ppat.1000687-Lafont2"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafont</surname><given-names>F</given-names></name><name><surname>van der Goot</surname><given-names>FG</given-names></name></person-group><year>2005</year><article-title>Bacterial invasion via lipid rafts.</article-title><source>Cell Microbiol</source><volume>7</volume><fpage>613</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">15839890</pub-id></mixed-citation></ref><ref id="ppat.1000687-Tamilselvam1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamilselvam</surname><given-names>B</given-names></name><name><surname>Daefler</surname><given-names>S</given-names></name></person-group><year>2008</year><article-title>Francisella Targets Cholesterol-Rich Host Cell Membrane Domains for Entry into Macrophages.</article-title><source>The Journal of Immunology</source><volume>180</volume><fpage>8262</fpage><lpage>8271</lpage><pub-id pub-id-type="pmid">18523292</pub-id></mixed-citation></ref><ref id="ppat.1000687-Zaas1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaas</surname><given-names>DW</given-names></name><name><surname>Duncan</surname><given-names>M</given-names></name><name><surname>Rae Wright</surname><given-names>J</given-names></name><name><surname>Abraham</surname><given-names>SN</given-names></name></person-group><year>2005</year><article-title>The role of lipid rafts in the pathogenesis of bacterial infections.</article-title><source>Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1746</volume><fpage>305</fpage><lpage>313</lpage></mixed-citation></ref><ref id="ppat.1000687-Stefanova1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanova</surname><given-names>I</given-names></name><name><surname>Horejsi</surname><given-names>V</given-names></name><name><surname>Ansotegui</surname><given-names>I</given-names></name><name><surname>Knapp</surname><given-names>W</given-names></name><name><surname>Stockinger</surname><given-names>H</given-names></name></person-group><year>1991</year><article-title>GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.</article-title><source>Science</source><volume>254</volume><fpage>1016</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">1719635</pub-id></mixed-citation></ref><ref id="ppat.1000687-Kramer1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>E-M</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Koch</surname><given-names>T</given-names></name><name><surname>Boytinck</surname><given-names>M</given-names></name><name><surname>Trotter</surname><given-names>J</given-names></name></person-group><year>1999</year><article-title>Compartmentation of Fyn Kinase with Glycosylphosphatidylinositol-anchored Molecules in Oligodendrocytes Facilitates Kinase Activation during Myelination.</article-title><source>J Biol Chem</source><volume>274</volume><fpage>29042</fpage><lpage>29049</lpage><pub-id pub-id-type="pmid">10506155</pub-id></mixed-citation></ref><ref id="ppat.1000687-Suzuki1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>KGN</given-names></name><name><surname>Fujiwara</surname><given-names>TK</given-names></name><name><surname>Edidin</surname><given-names>M</given-names></name><name><surname>Kusumi</surname><given-names>A</given-names></name></person-group><year>2007</year><article-title>Dynamic recruitment of phospholipase C{gamma} at transiently immobilized GPI-anchored receptor clusters induces IP3-Ca2&#x0002b; signaling: single-molecule tracking study 2.</article-title><source>J Cell Biol</source><volume>177</volume><fpage>731</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">17517965</pub-id></mixed-citation></ref><ref id="ppat.1000687-Suzuki2"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>KGN</given-names></name><name><surname>Fujiwara</surname><given-names>TK</given-names></name><name><surname>Sanematsu</surname><given-names>F</given-names></name><name><surname>Iino</surname><given-names>R</given-names></name><name><surname>Edidin</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>GPI-anchored receptor clusters transiently recruit Lyn and G{alpha} for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1.</article-title><source>J Cell Biol</source><volume>177</volume><fpage>717</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">17517964</pub-id></mixed-citation></ref><ref id="ppat.1000687-Schieven1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schieven</surname><given-names>GL</given-names></name></person-group><year>2005</year><article-title>The biology of p38 kinase: a central role in inflammation.</article-title><source>Curr Top Med Chem</source><volume>5</volume><fpage>921</fpage><lpage>928</lpage><pub-id pub-id-type="pmid">16178737</pub-id></mixed-citation></ref><ref id="ppat.1000687-Blander1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blander</surname><given-names>JM</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><year>2004</year><article-title>Regulation of phagosome maturation by signals from toll-like receptors.</article-title><source>Science</source><volume>304</volume><fpage>1014</fpage><lpage>1018</lpage><pub-id pub-id-type="pmid">15143282</pub-id></mixed-citation></ref><ref id="ppat.1000687-Olson1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>CM</given-names></name><name><surname>Hedrick</surname><given-names>MN</given-names></name><name><surname>Izadi</surname><given-names>H</given-names></name><name><surname>Bates</surname><given-names>TC</given-names></name><name><surname>Olivera</surname><given-names>ER</given-names></name><etal/></person-group><year>2007</year><article-title>p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens.</article-title><source>Infect Immun</source><volume>75</volume><fpage>270</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">17074860</pub-id></mixed-citation></ref><ref id="ppat.1000687-Dean1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>JLE</given-names></name><name><surname>Sully</surname><given-names>G</given-names></name><name><surname>Clark</surname><given-names>AR</given-names></name><name><surname>Saklatvala</surname><given-names>J</given-names></name></person-group><year>2004</year><article-title>The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation.</article-title><source>Cell Signal</source><volume>16</volume><fpage>1113</fpage><lpage>1121</lpage><pub-id pub-id-type="pmid">15240006</pub-id></mixed-citation></ref><ref id="ppat.1000687-Ropert1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ropert</surname><given-names>C</given-names></name><name><surname>Closel</surname><given-names>M</given-names></name><name><surname>Chaves</surname><given-names>AC</given-names></name><name><surname>Gazzinelli</surname><given-names>RT</given-names></name></person-group><year>2003</year><article-title>Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages.</article-title><source>J Immunol</source><volume>171</volume><fpage>1456</fpage><lpage>1465</lpage><pub-id pub-id-type="pmid">12874238</pub-id></mixed-citation></ref><ref id="ppat.1000687-Chi1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>H</given-names></name><name><surname>Barry</surname><given-names>SP</given-names></name><name><surname>Roth</surname><given-names>RJ</given-names></name><name><surname>Wu</surname><given-names>JJ</given-names></name><name><surname>Jones</surname><given-names>EA</given-names></name><etal/></person-group><year>2006</year><article-title>Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>2274</fpage><lpage>2279</lpage><pub-id pub-id-type="pmid">16461893</pub-id></mixed-citation></ref><ref id="ppat.1000687-Bode1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>JG</given-names></name><name><surname>Ludwig</surname><given-names>S</given-names></name><name><surname>Freitas</surname><given-names>CA</given-names></name><name><surname>Schaper</surname><given-names>F</given-names></name><name><surname>Ruhl</surname><given-names>M</given-names></name><etal/></person-group><year>2001</year><article-title>The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription.</article-title><source>Biol Chem</source><volume>382</volume><fpage>1447</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">11727828</pub-id></mixed-citation></ref><ref id="ppat.1000687-Medvedev1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medvedev</surname><given-names>AE</given-names></name><name><surname>Sabroe</surname><given-names>I</given-names></name><name><surname>Hasday</surname><given-names>JD</given-names></name><name><surname>Vogel</surname><given-names>SN</given-names></name></person-group><year>2006</year><article-title>Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease.</article-title><source>J Endotoxin Res</source><volume>12</volume><fpage>133</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">16719986</pub-id></mixed-citation></ref><ref id="ppat.1000687-Foster1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>SL</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><year>2009</year><article-title>Gene-specific control of the TLR-induced inflammatory response.</article-title><source>Clin Immunol</source><volume>130</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">18964303</pub-id></mixed-citation></ref><ref id="ppat.1000687-Liew1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liew</surname><given-names>FY</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Brint</surname><given-names>EK</given-names></name><name><surname>O'Neill</surname><given-names>LA</given-names></name></person-group><year>2005</year><article-title>Negative regulation of toll-like receptor-mediated immune responses.</article-title><source>Nat Rev Immunol</source><volume>5</volume><fpage>446</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">15928677</pub-id></mixed-citation></ref><ref id="ppat.1000687-Saito1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Morita</surname><given-names>Y</given-names></name><name><surname>Fujimoto</surname><given-names>M</given-names></name><name><surname>Narazaki</surname><given-names>M</given-names></name><name><surname>Naka</surname><given-names>T</given-names></name><etal/></person-group><year>2000</year><article-title>IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma.</article-title><source>J Immunol</source><volume>164</volume><fpage>5833</fpage><lpage>5843</lpage><pub-id pub-id-type="pmid">10820262</pub-id></mixed-citation></ref><ref id="ppat.1000687-Croker1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croker</surname><given-names>BA</given-names></name><name><surname>Krebs</surname><given-names>DL</given-names></name><name><surname>Zhang</surname><given-names>JG</given-names></name><name><surname>Wormald</surname><given-names>S</given-names></name><name><surname>Willson</surname><given-names>TA</given-names></name><etal/></person-group><year>2003</year><article-title>SOCS3 negatively regulates IL-6 signaling in vivo.</article-title><source>Nat Immunol</source><volume>4</volume><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">12754505</pub-id></mixed-citation></ref><ref id="ppat.1000687-Moody1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moody</surname><given-names>KD</given-names></name><name><surname>Barthold</surname><given-names>SW</given-names></name></person-group><year>1998</year><article-title>Lyme borreliosis in laboratory mice.</article-title><source>Lab Anim Sci</source><volume>48</volume><fpage>168</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">10090008</pub-id></mixed-citation></ref><ref id="ppat.1000687-Ma1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Seiler</surname><given-names>KP</given-names></name><name><surname>Eichwald</surname><given-names>EJ</given-names></name><name><surname>Weis</surname><given-names>JH</given-names></name><name><surname>Teuscher</surname><given-names>C</given-names></name><etal/></person-group><year>1998</year><article-title>Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.</article-title><source>Infect Immun</source><volume>66</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">9423853</pub-id></mixed-citation></ref><ref id="ppat.1000687-Gresham1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gresham</surname><given-names>H</given-names></name><name><surname>Clement</surname><given-names>L</given-names></name><name><surname>Lehmeyer</surname><given-names>J</given-names></name><name><surname>Griffin</surname><given-names>F</given-names><suffix>Jr</suffix></name><name><surname>Volanakis</surname><given-names>J</given-names></name></person-group><year>1986</year><article-title>Stimulation of human neutrophil Fc receptor-mediated phagocytosis by a low molecular weight cytokine.</article-title><source>J Immunol</source><volume>137</volume><fpage>868</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">3522738</pub-id></mixed-citation></ref><ref id="ppat.1000687-Flannagan1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Cosio</surname><given-names>G</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year>2009</year><article-title>Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.</article-title><source>Nat Rev Microbiol</source><volume>7</volume><fpage>355</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">19369951</pub-id></mixed-citation></ref><ref id="ppat.1000687-Steinberg1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>BE</given-names></name><name><surname>Huynh</surname><given-names>KK</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year>2007</year><article-title>Phagosomal acidification: measurement, manipulation and functional consequences.</article-title><source>Biochem Soc Trans</source><volume>35</volume><fpage>1083</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">17956285</pub-id></mixed-citation></ref><ref id="ppat.1000687-Li1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JD</given-names></name></person-group><year>2003</year><article-title>Exploitation of host epithelial signaling networks by respiratory bacterial pathogens.</article-title><source>J Pharmacol Sci</source><volume>91</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12686724</pub-id></mixed-citation></ref><ref id="ppat.1000687-Hollenbach1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenbach</surname><given-names>E</given-names></name><name><surname>Neumann</surname><given-names>M</given-names></name><name><surname>Vieth</surname><given-names>M</given-names></name><name><surname>Roessner</surname><given-names>A</given-names></name><name><surname>Malfertheiner</surname><given-names>P</given-names></name><etal/></person-group><year>2004</year><article-title>Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.</article-title><source>FASEB J</source><volume>18</volume><fpage>1550</fpage><lpage>1552</lpage><pub-id pub-id-type="pmid">15289440</pub-id></mixed-citation></ref><ref id="ppat.1000687-Kim1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Chong</surname><given-names>YH</given-names></name><name><surname>Kang</surname><given-names>JL</given-names></name></person-group><year>2006</year><article-title>p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages.</article-title><source>Toxicology</source><volume>225</volume><fpage>36</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">16793190</pub-id></mixed-citation></ref><ref id="ppat.1000687-Liu1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>GL</given-names></name><name><surname>Liu</surname><given-names>GJ</given-names></name></person-group><year>2008</year><article-title>p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway.</article-title><source>Eur J Pharmacol</source><volume>584</volume><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">18328478</pub-id></mixed-citation></ref><ref id="ppat.1000687-Nash1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nash</surname><given-names>SP</given-names></name><name><surname>Heuertz</surname><given-names>RM</given-names></name></person-group><year>2005</year><article-title>Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model.</article-title><source>Int Immunopharmacol</source><volume>5</volume><fpage>1870</fpage><lpage>1880</lpage><pub-id pub-id-type="pmid">16275622</pub-id></mixed-citation></ref><ref id="ppat.1000687-Cruz1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>AR</given-names></name><name><surname>Moore</surname><given-names>MW</given-names></name><name><surname>La Vake</surname><given-names>CJ</given-names></name><name><surname>Eggers</surname><given-names>CH</given-names></name><name><surname>Salazar</surname><given-names>JC</given-names></name><etal/></person-group><year>2008</year><article-title>Phagocytosis of Borrelia burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytes.</article-title><source>Infect Immun</source><volume>76</volume><fpage>56</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">17938216</pub-id></mixed-citation></ref><ref id="ppat.1000687-Moore1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>MW</given-names></name><name><surname>Cruz</surname><given-names>AR</given-names></name><name><surname>LaVake</surname><given-names>CJ</given-names></name><name><surname>Marzo</surname><given-names>AL</given-names></name><name><surname>Eggers</surname><given-names>CH</given-names></name><etal/></person-group><year>2007</year><article-title>Phagocytosis of Borrelia burgdorferi and Treponema pallidum Potentiates Innate Immune Activation and Induces Gamma Interferon Production.</article-title><source>Infect Immun</source><volume>75</volume><fpage>2046</fpage><lpage>2062</lpage><pub-id pub-id-type="pmid">17220323</pub-id></mixed-citation></ref><ref id="ppat.1000687-Gratton1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratton</surname><given-names>JP</given-names></name><name><surname>Morales-Ruiz</surname><given-names>M</given-names></name><name><surname>Kureishi</surname><given-names>Y</given-names></name><name><surname>Fulton</surname><given-names>D</given-names></name><name><surname>Walsh</surname><given-names>K</given-names></name><etal/></person-group><year>2001</year><article-title>Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>30359</fpage><lpage>30365</lpage><pub-id pub-id-type="pmid">11387313</pub-id></mixed-citation></ref><ref id="ppat.1000687-Kim2"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>AH</given-names></name><name><surname>Khursigara</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Franke</surname><given-names>TF</given-names></name><name><surname>Chao</surname><given-names>MV</given-names></name></person-group><year>2001</year><article-title>Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1.</article-title><source>Mol Cell Biol</source><volume>21</volume><fpage>893</fpage><lpage>901</lpage><pub-id pub-id-type="pmid">11154276</pub-id></mixed-citation></ref><ref id="ppat.1000687-Ferby1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferby</surname><given-names>IM</given-names></name><name><surname>Waga</surname><given-names>I</given-names></name><name><surname>Sakanaka</surname><given-names>C</given-names></name><name><surname>Kume</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name></person-group><year>1994</year><article-title>Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils.</article-title><source>J Biol Chem</source><volume>269</volume><fpage>30485</fpage><lpage>30488</lpage><pub-id pub-id-type="pmid">7982965</pub-id></mixed-citation></ref><ref id="ppat.1000687-Knight1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>ZA</given-names></name><name><surname>Gonzalez</surname><given-names>B</given-names></name><name><surname>Feldman</surname><given-names>ME</given-names></name><name><surname>Zunder</surname><given-names>ER</given-names></name><name><surname>Goldenberg</surname><given-names>DD</given-names></name><etal/></person-group><year>2006</year><article-title>A Pharmacological Map of the PI3-K Family Defines a Role for p110&#x0005b;alpha&#x0005d; in Insulin Signaling.</article-title><source>Cell</source><volume>125</volume><fpage>733</fpage><lpage>747</lpage><pub-id pub-id-type="pmid">16647110</pub-id></mixed-citation></ref><ref id="ppat.1000687-Arcaro1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcaro</surname><given-names>A</given-names></name><name><surname>Aubert</surname><given-names>M</given-names></name><name><surname>Espinosa del Hierro</surname><given-names>ME</given-names></name><name><surname>Khanzada</surname><given-names>UK</given-names></name><name><surname>Angelidou</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.</article-title><source>Cell Signal</source><volume>19</volume><fpage>1081</fpage><lpage>1092</lpage><pub-id pub-id-type="pmid">17275257</pub-id></mixed-citation></ref><ref id="ppat.1000687-Dermine1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dermine</surname><given-names>JF</given-names></name><name><surname>Duclos</surname><given-names>S</given-names></name><name><surname>Garin</surname><given-names>J</given-names></name><name><surname>St-Louis</surname><given-names>F</given-names></name><name><surname>Rea</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>18507</fpage><lpage>18512</lpage><pub-id pub-id-type="pmid">11279173</pub-id></mixed-citation></ref><ref id="ppat.1000687-Matsuzawa1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzawa</surname><given-names>A</given-names></name><name><surname>Saegusa</surname><given-names>K</given-names></name><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Sadamitsu</surname><given-names>C</given-names></name><name><surname>Nishitoh</surname><given-names>H</given-names></name><etal/></person-group><year>2005</year><article-title>ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity.</article-title><source>Nat Immunol</source><volume>6</volume><fpage>587</fpage><lpage>592</lpage><pub-id pub-id-type="pmid">15864310</pub-id></mixed-citation></ref><ref id="ppat.1000687-Wooten2"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname><given-names>RM</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Yoder</surname><given-names>RA</given-names></name><name><surname>Brown</surname><given-names>JP</given-names></name><name><surname>Weis</surname><given-names>JH</given-names></name><etal/></person-group><year>2002</year><article-title>Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi.</article-title><source>Vector Borne Zoonotic Dis</source><volume>2</volume><fpage>275</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">12804169</pub-id></mixed-citation></ref><ref id="ppat.1000687-Wooten3"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname><given-names>RM</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Yoder</surname><given-names>RA</given-names></name><name><surname>Brown</surname><given-names>JP</given-names></name><name><surname>Weis</surname><given-names>JH</given-names></name><etal/></person-group><year>2002</year><article-title>Toll-Like Receptor 2 Is Required for Innate, But Not Acquired, Host Defense to Borrelia burgdorferi.</article-title><source>J Immunol</source><volume>168</volume><fpage>348</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">11751980</pub-id></mixed-citation></ref><ref id="ppat.1000687-Wooten4"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname><given-names>RM</given-names></name><name><surname>Morrison</surname><given-names>TB</given-names></name><name><surname>Weis</surname><given-names>JH</given-names></name><name><surname>Wright</surname><given-names>SD</given-names></name><name><surname>Thieringer</surname><given-names>R</given-names></name><etal/></person-group><year>1998</year><article-title>The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi.</article-title><source>J Immunol</source><volume>160</volume><fpage>5485</fpage><lpage>5492</lpage><pub-id pub-id-type="pmid">9605151</pub-id></mixed-citation></ref><ref id="ppat.1000687-Mayor1"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayor</surname><given-names>S</given-names></name><name><surname>Riezman</surname><given-names>H</given-names></name></person-group><year>2004</year><article-title>Sorting GPI-anchored proteins.</article-title><source>Nat Rev Mol Cell Biol</source><volume>5</volume><fpage>110</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">15040444</pub-id></mixed-citation></ref><ref id="ppat.1000687-Brown1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DA</given-names></name><name><surname>Rose</surname><given-names>JK</given-names></name></person-group><year>1992</year><article-title>Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface.</article-title><source>Cell</source><volume>68</volume><fpage>533</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">1531449</pub-id></mixed-citation></ref><ref id="ppat.1000687-Brown2"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>D</given-names></name></person-group><year>1994</year><article-title>GPI-anchored proteins and detergent-resistant membrane domains.</article-title><source>Braz J Med Biol Res</source><volume>27</volume><fpage>309</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">8081244</pub-id></mixed-citation></ref><ref id="ppat.1000687-Leupin1"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leupin</surname><given-names>O</given-names></name><name><surname>Zaru</surname><given-names>R</given-names></name><name><surname>Laroche</surname><given-names>T</given-names></name><name><surname>Muller</surname><given-names>S</given-names></name><name><surname>Valitutti</surname><given-names>S</given-names></name></person-group><year>2000</year><article-title>Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes.</article-title><source>Curr Biol</source><volume>10</volume><fpage>277</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">10712909</pub-id></mixed-citation></ref><ref id="ppat.1000687-Rosenberger1"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberger</surname><given-names>CM</given-names></name><name><surname>Brumell</surname><given-names>JH</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group><year>2000</year><article-title>Microbial pathogenesis: lipid rafts as pathogen portals.</article-title><source>Curr Biol</source><volume>10</volume><fpage>R823</fpage><lpage>R825</lpage><pub-id pub-id-type="pmid">11102822</pub-id></mixed-citation></ref><ref id="ppat.1000687-Pfeiffer1"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>A</given-names></name><name><surname>Bottcher</surname><given-names>A</given-names></name><name><surname>Orso</surname><given-names>E</given-names></name><name><surname>Kapinsky</surname><given-names>M</given-names></name><name><surname>Nagy</surname><given-names>P</given-names></name><etal/></person-group><year>2001</year><article-title>Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts.</article-title><source>Eur J Immunol</source><volume>31</volume><fpage>3153</fpage><lpage>3164</lpage><pub-id pub-id-type="pmid">11745332</pub-id></mixed-citation></ref><ref id="ppat.1000687-Yeung1"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>T</given-names></name><name><surname>Terebiznik</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Silvius</surname><given-names>J</given-names></name><name><surname>Abidi</surname><given-names>WM</given-names></name><etal/></person-group><year>2006</year><article-title>Receptor activation alters inner surface potential during phagocytosis.</article-title><source>Science</source><volume>313</volume><fpage>347</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">16857939</pub-id></mixed-citation></ref><ref id="ppat.1000687-Yeung2"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>T</given-names></name><name><surname>Ozdamar</surname><given-names>B</given-names></name><name><surname>Paroutis</surname><given-names>P</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year>2006</year><article-title>Lipid metabolism and dynamics during phagocytosis.</article-title><source>Curr Opin Cell Biol</source><volume>18</volume><fpage>429</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">16781133</pub-id></mixed-citation></ref><ref id="ppat.1000687-Graeme1"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graeme</surname><given-names>F</given-names></name><name><surname>Nixon</surname></name></person-group><year>2009</year><article-title>Sphingolipids in inflammation: pathological implications and potential therapeutic targets.</article-title><source>Br J Pharmacol</source><volume>9999</volume></mixed-citation></ref><ref id="ppat.1000687-AbdelShakor1"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel Shakor</surname><given-names>AB</given-names></name><name><surname>Kwiatkowska</surname><given-names>K</given-names></name><name><surname>Sobota</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>Cell surface ceramide generation precedes and controls FcgammaRII clustering and phosphorylation in rafts.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>36778</fpage><lpage>36787</lpage><pub-id pub-id-type="pmid">15194692</pub-id></mixed-citation></ref><ref id="ppat.1000687-Shin1"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>OS</given-names></name><name><surname>Miller</surname><given-names>LS</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Uematsu</surname><given-names>S</given-names></name><etal/></person-group><year>2009</year><article-title>Downstream Signals for MyD88-Mediated Phagocytosis of Borrelia burgdorferi Can Be Initiated by TRIF and Are Dependent on PI3K.</article-title><source>J Immunol</source><volume>183</volume><fpage>491</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">19542460</pub-id></mixed-citation></ref><ref id="ppat.1000687-Cinco1"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinco</surname><given-names>M</given-names></name><name><surname>Murgia</surname><given-names>R</given-names></name><name><surname>Presani</surname><given-names>G</given-names></name><name><surname>Perticarari</surname><given-names>S</given-names></name></person-group><year>1997</year><article-title>Integrin CR3 mediates the binding of nonspecifically opsonized Borrelia burgdorferi to human phagocytes and mammalian cells.</article-title><source>Infect Immun</source><volume>65</volume><fpage>4784</fpage><lpage>4789</lpage><pub-id pub-id-type="pmid">9353065</pub-id></mixed-citation></ref><ref id="ppat.1000687-Coburn1"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coburn</surname><given-names>J</given-names></name><name><surname>Cugini</surname><given-names>C</given-names></name></person-group><year>2003</year><article-title>Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin alphavbeta3.</article-title><source>Proc Natl Acad Sci USA</source><volume>100</volume><fpage>7301</fpage><lpage>7306</lpage><pub-id pub-id-type="pmid">12748384</pub-id></mixed-citation></ref><ref id="ppat.1000687-GueraudeArellano1"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerau-de-Arellano</surname><given-names>M</given-names></name><name><surname>Alroy</surname><given-names>J</given-names></name><name><surname>Huber</surname><given-names>BT</given-names></name></person-group><year>2005</year><article-title>Beta2 integrins control the severity of murine Lyme carditis.</article-title><source>Infect Immun</source><volume>73</volume><fpage>3242</fpage><lpage>3250</lpage><pub-id pub-id-type="pmid">15908348</pub-id></mixed-citation></ref><ref id="ppat.1000687-Behera1"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behera</surname><given-names>AK</given-names></name><name><surname>Hildebrand</surname><given-names>E</given-names></name><name><surname>Uematsu</surname><given-names>S</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Coburn</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1.</article-title><source>The Journal of Immunology</source><volume>177</volume><fpage>657</fpage><lpage>664</lpage><pub-id pub-id-type="pmid">16785564</pub-id></mixed-citation></ref><ref id="ppat.1000687-Antonara1"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonara</surname><given-names>S</given-names></name><name><surname>Chafel</surname><given-names>RM</given-names></name><name><surname>LaFrance</surname><given-names>M</given-names></name><name><surname>Coburn</surname><given-names>J</given-names></name></person-group><year>2007</year><article-title>Borrelia burgdorferi adhesins identified using in vivo phage display.</article-title><source>Mol Microbiol</source><volume>66</volume><fpage>262</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">17784908</pub-id></mixed-citation></ref><ref id="ppat.1000687-Behera2"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behera</surname><given-names>AK</given-names></name><name><surname>Durand</surname><given-names>E</given-names></name><name><surname>Cugini</surname><given-names>C</given-names></name><name><surname>Antonara</surname><given-names>S</given-names></name><name><surname>Bourassa</surname><given-names>L</given-names></name><etal/></person-group><year>2008</year><article-title>Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes.</article-title><source>Cell Microbiol</source><volume>10</volume><fpage>320</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">17822440</pub-id></mixed-citation></ref><ref id="ppat.1000687-Liu2"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Montgomery</surname><given-names>RR</given-names></name><name><surname>Barthold</surname><given-names>SW</given-names></name><name><surname>Bockenstedt</surname><given-names>LK</given-names></name></person-group><year>2004</year><article-title>Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice.</article-title><source>Infect Immun</source><volume>72</volume><fpage>3195</fpage><lpage>3203</lpage><pub-id pub-id-type="pmid">15155621</pub-id></mixed-citation></ref><ref id="ppat.1000687-Shin2"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>OS</given-names></name><name><surname>Isberg</surname><given-names>RR</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Uematsu</surname><given-names>S</given-names></name><name><surname>Behera</surname><given-names>AK</given-names></name><etal/></person-group><year>2008</year><article-title>Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction.</article-title><source>Infect Immun</source><volume>76</volume><fpage>2341</fpage><lpage>2351</lpage><pub-id pub-id-type="pmid">18378636</pub-id></mixed-citation></ref><ref id="ppat.1000687-Schiff1"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiff</surname><given-names>DE</given-names></name><name><surname>Kline</surname><given-names>L</given-names></name><name><surname>Soldau</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Pugin</surname><given-names>J</given-names></name><etal/></person-group><year>1997</year><article-title>Phagocytosis of gram-negative bacteria by a unique CD14-dependent mechanism.</article-title><source>J Leukocyte Biol</source><volume>62</volume><fpage>786</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">9400820</pub-id></mixed-citation></ref><ref id="ppat.1000687-Pancewicz1"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pancewicz</surname><given-names>SA</given-names></name><name><surname>Skrzydlewska</surname><given-names>E</given-names></name><name><surname>Hermanowska-Szpakowicz</surname><given-names>T</given-names></name><name><surname>Zajkowska</surname><given-names>JM</given-names></name><name><surname>Kondrusik</surname><given-names>M</given-names></name></person-group><year>2001</year><article-title>Role of reactive oxygen species (ROS) in patients with erythema migrans, an early manifestation of Lyme borreliosis.</article-title><source>Med Sci Monit</source><volume>7</volume><fpage>1230</fpage><lpage>1235</lpage><pub-id pub-id-type="pmid">11687735</pub-id></mixed-citation></ref><ref id="ppat.1000687-Marangoni1"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marangoni</surname><given-names>A</given-names></name><name><surname>Accardo</surname><given-names>S</given-names></name><name><surname>Aldini</surname><given-names>R</given-names></name><name><surname>Guardigli</surname><given-names>M</given-names></name><name><surname>Cavrini</surname><given-names>F</given-names></name><etal/></person-group><year>2006</year><article-title>Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi.</article-title><source>World J Gastroenterol</source><volume>12</volume><fpage>3077</fpage><lpage>3081</lpage><pub-id pub-id-type="pmid">16718791</pub-id></mixed-citation></ref><ref id="ppat.1000687-Boylan1"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boylan</surname><given-names>JA</given-names></name><name><surname>Gherardini</surname><given-names>FC</given-names></name></person-group><year>2008</year><article-title>Determining the cellular targets of reactive oxygen species in Borrelia burgdorferi.</article-title><source>Methods Mol Biol</source><volume>431</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">18287759</pub-id></mixed-citation></ref><ref id="ppat.1000687-Boylan2"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boylan</surname><given-names>JA</given-names></name><name><surname>Lawrence</surname><given-names>KA</given-names></name><name><surname>Downey</surname><given-names>JS</given-names></name><name><surname>Gherardini</surname><given-names>FC</given-names></name></person-group><year>2008</year><article-title>Borrelia burgdorferi membranes are the primary targets of reactive oxygen species.</article-title><source>Mol Microbiol</source><volume>68</volume><fpage>786</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">18373524</pub-id></mixed-citation></ref><ref id="ppat.1000687-Anderson1"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JM</given-names></name><name><surname>Valenzuela</surname><given-names>JG</given-names></name></person-group><year>2007</year><article-title>Spit-acular entry: Borrelia gets help from a tick salivary protein to move from the mammalian host to the arthropod vector.</article-title><source>Cell Host Microbe</source><volume>2</volume><fpage>3</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">18005711</pub-id></mixed-citation></ref><ref id="ppat.1000687-Narasimhan1"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narasimhan</surname><given-names>S</given-names></name><name><surname>Sukumaran</surname><given-names>B</given-names></name><name><surname>Bozdogan</surname><given-names>U</given-names></name><name><surname>Thomas</surname><given-names>V</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><etal/></person-group><year>2007</year><article-title>A tick antioxidant facilitates the Lyme disease agent's successful migration from the mammalian host to the arthropod vector.</article-title><source>Cell Host Microbe</source><volume>2</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">18005713</pub-id></mixed-citation></ref><ref id="ppat.1000687-Guo1"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Booth</surname><given-names>CJ</given-names></name><name><surname>Paley</surname><given-names>MA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>DePonte</surname><given-names>K</given-names></name><etal/></person-group><year>2009</year><article-title>Inhibition of Neutrophil Function by Two Tick Salivary Proteins.</article-title><source>Infect Immun</source><volume>77</volume><fpage>2320</fpage><lpage>2329</lpage><pub-id pub-id-type="pmid">19332533</pub-id></mixed-citation></ref><ref id="ppat.1000687-Liu3"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wenzel</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>BH</given-names></name><etal/></person-group><year>2006</year><article-title>Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.</article-title><source>Science</source><volume>311</volume><fpage>1770</fpage><lpage>1773</lpage><pub-id pub-id-type="pmid">16497887</pub-id></mixed-citation></ref><ref id="ppat.1000687-Krisanaprakornkit1"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krisanaprakornkit</surname><given-names>S</given-names></name><name><surname>Kimball</surname><given-names>JR</given-names></name><name><surname>Dale</surname><given-names>BA</given-names></name></person-group><year>2002</year><article-title>Regulation of Human {beta}-Defensin-2 in Gingival Epithelial Cells: The Involvement of Mitogen-Activated Protein Kinase Pathways, But Not the NF-{kappa}B Transcription Factor Family.</article-title><source>J Immunol</source><volume>168</volume><fpage>316</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">11751976</pub-id></mixed-citation></ref><ref id="ppat.1000687-Koji1"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koji</surname><given-names>S</given-names></name><name><surname>Hitoshi</surname><given-names>K</given-names></name><name><surname>Kenshi</surname><given-names>Y</given-names></name><name><surname>Yuji</surname><given-names>S</given-names></name><name><surname>Yasushi</surname><given-names>H</given-names></name><etal/></person-group><year>2005</year><article-title>New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of &#x003b2;-defensins, LL37, and TLR2.</article-title><source>Eur J Immunol</source><volume>35</volume><fpage>1886</fpage><lpage>1895</lpage><pub-id pub-id-type="pmid">15864780</pub-id></mixed-citation></ref><ref id="ppat.1000687-Wehkamp1"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehkamp</surname><given-names>K</given-names></name><name><surname>Schwichtenberg</surname><given-names>L</given-names></name><name><surname>Schroder</surname><given-names>J-MM</given-names></name><name><surname>Harder</surname><given-names>J.</given-names></name></person-group><article-title>Pseudomonas Aeruginosa- and IL-1&#x0005b;beta&#x0005d;-Mediated Induction of Human &#x0005b;beta&#x0005d;-Defensin-2 in Keratinocytes Is Controlled by NF-&#x0005b;kappa&#x0005d;B and AP-1.</article-title><source>J Invest Dermatol</source><volume>126</volume><fpage>121</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">16417227</pub-id></mixed-citation></ref><ref id="ppat.1000687-Adams1"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Lagishetty</surname><given-names>V</given-names></name><etal/></person-group><year>2009</year><article-title>Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial Responses.</article-title><source>J Immunol</source><volume>182</volume><fpage>4289</fpage><lpage>4295</lpage><pub-id pub-id-type="pmid">19299728</pub-id></mixed-citation></ref><ref id="ppat.1000687-Salazar1"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salazar</surname><given-names>JC</given-names></name><name><surname>Duhnam-Ems</surname><given-names>S</given-names></name><name><surname>La Vake</surname><given-names>C</given-names></name><name><surname>Cruz</surname><given-names>AR</given-names></name><name><surname>Moore</surname><given-names>MW</given-names></name><etal/></person-group><year>2009</year><article-title>Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta.</article-title><source>PLoS Pathog</source><volume>5</volume><fpage>e1000444</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1000444">10.1371/journal.ppat.1000444</ext-link></comment><pub-id pub-id-type="pmid">19461888</pub-id></mixed-citation></ref><ref id="ppat.1000687-vandenBlink1"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Blink</surname><given-names>B</given-names></name><name><surname>Juffermans</surname><given-names>NP</given-names></name><name><surname>ten Hove</surname><given-names>T</given-names></name><name><surname>Schultz</surname><given-names>MJ</given-names></name><name><surname>van Deventer</surname><given-names>SJH</given-names></name><etal/></person-group><year>2001</year><article-title>p38 Mitogen-Activated Protein Kinase Inhibition Increases Cytokine Release by Macrophages In Vitro and During Infection In Vivo.</article-title><source>J Immunol</source><volume>166</volume><fpage>582</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">11123340</pub-id></mixed-citation></ref><ref id="ppat.1000687-Ogura1"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>H</given-names></name><name><surname>Tsukumo</surname><given-names>Y</given-names></name><name><surname>Sugimoto</surname><given-names>H</given-names></name><name><surname>Igarashi</surname><given-names>M</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name><etal/></person-group><year>2008</year><article-title>ERK and p38 MAP kinase are involved in downregulation of cell surface TNF receptor 1 induced by acetoxycycloheximide.</article-title><source>Int Immunopharmacol</source><volume>8</volume><fpage>922</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">18442799</pub-id></mixed-citation></ref><ref id="ppat.1000687-Egan1"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>PJ</given-names></name><name><surname>Lawlor</surname><given-names>KE</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name><name><surname>Wicks</surname><given-names>IP</given-names></name></person-group><year>2003</year><article-title>Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation.</article-title><source>J Clin Invest</source><volume>111</volume><fpage>915</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">12639998</pub-id></mixed-citation></ref><ref id="ppat.1000687-Jo1"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>RD</given-names></name><name><surname>Hawiger</surname><given-names>J</given-names></name></person-group><year>2005</year><article-title>Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis.</article-title><source>Nat Med</source><volume>11</volume><fpage>892</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">16007096</pub-id></mixed-citation></ref><ref id="ppat.1000687-Shouda1"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shouda</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Hanada</surname><given-names>T</given-names></name><name><surname>Wakioka</surname><given-names>T</given-names></name><name><surname>Oishi</surname><given-names>M</given-names></name><etal/></person-group><year>2001</year><article-title>Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.</article-title><source>J Clin Invest</source><volume>108</volume><fpage>1781</fpage><lpage>1788</lpage><pub-id pub-id-type="pmid">11748261</pub-id></mixed-citation></ref><ref id="ppat.1000687-Murray1"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>RZ</given-names></name><name><surname>Kay</surname><given-names>JG</given-names></name><name><surname>Sangermani</surname><given-names>DG</given-names></name><name><surname>Stow</surname><given-names>JL</given-names></name></person-group><year>2005</year><article-title>A Role for the Phagosome in Cytokine Secretion.</article-title><source>Science</source><volume>310</volume><fpage>1492</fpage><lpage>1495</lpage><pub-id pub-id-type="pmid">16282525</pub-id></mixed-citation></ref><ref id="ppat.1000687-Albrecht1"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albrecht</surname><given-names>V</given-names></name><name><surname>Hofer</surname><given-names>T</given-names></name><name><surname>Foxwell</surname><given-names>B</given-names></name><name><surname>Frankenberger</surname><given-names>M</given-names></name><name><surname>Ziegler-Heitbrock</surname><given-names>L</given-names></name></person-group><year>2008</year><article-title>Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1.</article-title><source>BMC Immunol</source><volume>9</volume><fpage>69</fpage><pub-id pub-id-type="pmid">19025640</pub-id></mixed-citation></ref><ref id="ppat.1000687-Orio1"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orio</surname><given-names>M</given-names></name><name><surname>Kunz</surname><given-names>A</given-names></name><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Anrather</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><etal/></person-group><year>2007</year><article-title>Lipopolysaccharide Induces Early Tolerance to Excitotoxicity via Nitric Oxide and cGMP.</article-title><source>Stroke</source><volume>38</volume><fpage>2812</fpage><lpage>2817</lpage><pub-id pub-id-type="pmid">17761917</pub-id></mixed-citation></ref><ref id="ppat.1000687-Dennis1"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>VA</given-names></name><name><surname>Jefferson</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>SR</given-names></name><name><surname>Ganapamo</surname><given-names>F</given-names></name><name><surname>Philipp</surname><given-names>MT</given-names></name></person-group><year>2006</year><article-title>Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3.</article-title><source>Infect Immun</source><volume>74</volume><fpage>5780</fpage><lpage>5789</lpage><pub-id pub-id-type="pmid">16988256</pub-id></mixed-citation></ref><ref id="ppat.1000687-Diterich1"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diterich</surname><given-names>I</given-names></name><name><surname>Rauter</surname><given-names>C</given-names></name><name><surname>Kirschning</surname><given-names>CJ</given-names></name><name><surname>Hartung</surname><given-names>T</given-names></name></person-group><year>2003</year><article-title>Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression.</article-title><source>Infect Immun</source><volume>71</volume><fpage>3979</fpage><lpage>3987</lpage><pub-id pub-id-type="pmid">12819085</pub-id></mixed-citation></ref><ref id="ppat.1000687-Bode2"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>JG</given-names></name><name><surname>Nimmesgern</surname><given-names>A</given-names></name><name><surname>Schmitz</surname><given-names>J</given-names></name><name><surname>Schaper</surname><given-names>F</given-names></name><name><surname>Schmitt</surname><given-names>M</given-names></name><etal/></person-group><year>1999</year><article-title>LPS and TNF&#x0005b;alpha&#x0005d; induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages.</article-title><source>FEBS Lett</source><volume>463</volume><fpage>365</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">10606755</pub-id></mixed-citation></ref><ref id="ppat.1000687-Dimitriou1"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimitriou</surname><given-names>ID</given-names></name><name><surname>Clemenza</surname><given-names>L</given-names></name><name><surname>Scotter</surname><given-names>AJ</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Guerra</surname><given-names>FM</given-names></name><etal/></person-group><year>2008</year><article-title>Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins.</article-title><source>Immunol Rev</source><volume>224</volume><fpage>265</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">18759933</pub-id></mixed-citation></ref><ref id="ppat.1000687-Fan1"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Cook</surname><given-names>JA</given-names></name></person-group><year>2004</year><article-title>Molecular mechanisms of endotoxin tolerance.</article-title><source>J Endotoxin Res</source><volume>10</volume><fpage>71</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">15119998</pub-id></mixed-citation></ref><ref id="ppat.1000687-Mansell1"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansell</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Doyle</surname><given-names>SL</given-names></name><name><surname>Gray</surname><given-names>P</given-names></name><name><surname>Fenner</surname><given-names>JE</given-names></name><etal/></person-group><year>2006</year><article-title>Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation 6.</article-title><source>Nat Immunol</source><volume>7</volume><fpage>148</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">16415872</pub-id></mixed-citation></ref><ref id="ppat.1000687-Nakagawa1"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>R</given-names></name><name><surname>Naka</surname><given-names>T</given-names></name><name><surname>Tsutsui</surname><given-names>H</given-names></name><name><surname>Fujimoto</surname><given-names>M</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><etal/></person-group><year>2002</year><article-title>SOCS-1 participates in negative regulation of LPS responses.</article-title><source>Immunity</source><volume>17</volume><fpage>677</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">12433373</pub-id></mixed-citation></ref><ref id="ppat.1000687-Eggers1"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggers</surname><given-names>CH</given-names></name><name><surname>Caimano</surname><given-names>MJ</given-names></name><name><surname>Clawson</surname><given-names>ML</given-names></name><name><surname>Miller</surname><given-names>WG</given-names></name><name><surname>Samuels</surname><given-names>DS</given-names></name><etal/></person-group><year>2002</year><article-title>Identification of loci critical for replication and compatibility of a Borrelia burgdorferi cp32 plasmid and use of a cp32-based shuttle vector for the expression of fluorescent reporters in the lyme disease spirochaete.</article-title><source>Mol Microbiol</source><volume>43</volume><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">11985709</pub-id></mixed-citation></ref><ref id="ppat.1000687-Werts1"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werts</surname><given-names>C</given-names></name><name><surname>Tapping</surname><given-names>RI</given-names></name><name><surname>Mathison</surname><given-names>JC</given-names></name><name><surname>Chuang</surname><given-names>TH</given-names></name><name><surname>Kravchenko</surname><given-names>V</given-names></name><etal/></person-group><year>2001</year><article-title>Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism.</article-title><source>Nat Immunol</source><volume>2</volume><fpage>346</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">11276206</pub-id></mixed-citation></ref><ref id="ppat.1000687-Warren1"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>MK</given-names></name><name><surname>Vogel</surname><given-names>SN</given-names></name></person-group><year>1985</year><article-title>Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons.</article-title><source>J Immunol</source><volume>134</volume><fpage>982</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">2578168</pub-id></mixed-citation></ref><ref id="ppat.1000687-Reed1"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>LJ</given-names></name><name><surname>Muench</surname><given-names>H</given-names></name></person-group><year>1938</year><article-title>A simple method of estimating 50&#x00025; end point.</article-title><source>Am J Hyg</source><volume>27</volume><fpage>493</fpage></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>Supported by the National Institutes of Health (AI62439 to JCS, AI29735 and AI38894 to JDR, and AI054546 to TJS) and an Arthritis Foundation Investigator Award to TJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>